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ABSTRACT 
The extensive research interest in signaling through cGMP reveals an increasing 
number of cellular functions that are modulated by this molecule. cGMP signaling is 
involved in diverse processes such as vascular smooth muscle relaxation, prevention 
of platelet aggregation, angiogenesis, atherosclerosis learning and memory and 
perhaps many other (patho-) physiological functions that we do not know yet. Many 
commonly used medications are designed to target cGMP. For example, NO derived 
from the sublingual nitroglycerin pills increases the concentration of intracellular 
cGMP by activating the NO-GC (guanylyl cyclase activated by NO). The increase in 
cGMP causes dilation of blood vessels of the heart, facilitating cardiac oxygenation of 
people with coronary heart disease (angina pectoris). Transgenic mouse models 
have greatly contributed to dissect the in vivo functions of cGMP as well as other 
physiological processes and complex diseases. The present work describes the 
construction of a targeting vector to modify the murine Rosa26 locus by homologous 
recombination in embryonic stem cells. The construct was based on a published 
targeting vector that allows Cre/lox-induced switching between the expression of a 
membrane-targeted red fluorescent protein (mT) and a membrane-targeted green 
fluorescent protein (mG) from the Rosa26 locus (pR26mT/mG “A  global double-
fluorescent Cre reporter mouse”, Muzumdar et al., 2007). The aim was to replace the 
mG fragment in pR26mT/mG by a multiple cloning site (MCS), where we could 
subsequently sub-clone any gene/sequence of interest. The expression cassette is 
driven by the strong CAG promoter. It encodes a membrane-targeted red fluorescent 
protein variant (tandem dimer Tomato, tdTomato or mT) surrounded by loxP sites, 
followed by the MCS for unique enzymes. In the MCS we inserted a fluorescence 
resonance energy transfer (FRET)-based cGMP indicator, cGi500 in order to monitor 
in real time the cGMP levels in live cells/tissues (pR26mT/cGi500). Alternatively an 
improved version of the herpes simplex virus thymidine kinase (sr39tk) was inserted 
into the MCS. This reporter enzyme can be used for non-invasive cell tracking in 
mice. Finally to show that the constructs were functional, we transfected mouse 
embryonic fibroblasts with the above constructs (pR26mT/cGi500, pR26mT/mG) in 
the presence and absence of Cre recombinase. Indeed the experiment showed 
proper Cre-activatable expression of the constructs. The newly generated targeting 
vectors will now be used to produce gene-targeted mice for visualization of cGMP 
(cGi500 cGMP sensor) as well as for cell tracking (sr39tk reporter). 
Key words: cGMP, cGi-500, Cre/lox, targeting vector, sr39tk, transgenic mouse 
models, mT/mG, Cre-mediated recombination  
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Α. Introduction 
 
Α.1 cGMP Signaling   
The cGMP (cyclic guanosine monophosphate) is a molecule that signals the start of 
many cellular functions that are involved in disease and health conditions. Many 
ligands (hormones, neurotransmitters, toxins) cause cell response through cGMP. 
The biochemical mechanisms that are involved in this response include the 
composition, function and finally the degradation of cGMP. 
Α.1.1 Composition of cGMP- Guanylyl Cyclases 
Guanylyl cyclases (GC) is a family of enzymes that are expressed in almost all cells 
and catalyze the conversion of GTP → cGMP. They are divided into two categories: 
those that are bound to the membrane (particulate GC, pGC) and the soluble ones 
(soluble GC, sGC). 
  
Α.1.1.1 GCs located on the membrane (particulate GCs) 
Seven isomers of the mammalian pGCs have been identified so far (GC-A,-B,-C,-D,-
E,-F,-G).The pGCs based on their receptor specificity have been categorized into 
three groups: natriuretic peptide receptors, intestinal peptide receptors and orphan 
receptors. The GC-A,-B are activated by natriuretic peptides (ANP: atrial natriuretic 
peptide, BNP: brain natriuretic peptide, CNP: C-type natriuretic peptide. The GC-C 
was originally identified as the receptor of enterotoxins, but it can be also activated 
by endogenous mammalian peptides, such as guanylin, uroguanylin and 
lemphoguanylin. The GC-D is expressed in the olfactory epithelium and it appears to 
be involved in the recognition of pheromones. It is believed to act as an olfactory 
receptor. The GC-E,-F are expressed in the retina. Their ligands are yet unknown. 
The GC-G is expressed in the lungs and skeletal muscles, its ligands are unknown 
today [2]. 
Α.1.1.1.1 GC- receptors of natriuretic peptides  
The ANP (atrial natriuretic peptide) induces natriuresis, diuresis and hypotension and 
inhibits secretion of rennin and aldosterone. It also seems to be involved in 
electrolyte/ liquids balance. The BNP is a peptide isolated from the brain and it is also 
found in the heart and blood. The CNP also affects natriuresis and diuresis and the 
relaxation of smooth muscles of blood vessels but it is less active than ANP and 
BNP. The mechanism by which natriuretic peptides affect physiological functions 
includes the activation of GC-coupled receptors and the accumulation of cGMP in the 
cytoplasm [2]. 
Α.1.1.1.2  GC- intestinal peptide receptors  
The GC-C is mainly expressed in intestinal cells, but also in kidneys, testis, placenta 
and liver. It functions as a receptor for peptide hormones of guanylin family. The first 
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ligand that was identified was the enterotoxin somatostatin (STa) produced by E.coli 
bacteria, which activates the GC and increases cGMP in intestinal cells. The 
activation of GC-C by STa results in severe diarrhea in humans [2].  
Α.1.1.1.3  GC-orphan receptors 
The pGCs for which no ligands have been identified yet are classified as orphan 
receptors. Experiments have shown that ligands that activate other GCs do not 
activate GC-D,-E,-F,-G [2]. 
A.1.1.1.4 Structure of pGCs 
The pGCs consist of the following regions: 
 Extracellular ligand binding domain to the NH2 terminus 
 Transmembrane domain 
 Cytoplasmic region near the membrane 
 Kinase homology domain 
 Hinge region 
 A  carboxyl-terminal, catalytic domain 
 A carboxyl-terminal tail expressed in cells of intestine mucosa and in sensory 
organs (GC-C, GC-D,-E,-F) [2]. 
 
 
Picture 1 
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Domain structure of guanylyl cyclases. The cognate domains of ANPCRs, pGCs, and sGCs 
are compared. ANPCRs are homodimeric truncated guanylyl cyclases that possess 
extracellular ligand binding, transmembrane, and juxtamembrane domains but lack kinase 
homology, hinge, and catalytic domains. The pGC illustrated is a homodimer modeled after 
GC-A and -B and possesses a single ligand-binding site formed by two extracellular amino 
terminal domains. In addition to the domains present in ANPCRs, pGCs also possess kinase 
homology domains, hinge regions, and catalytic domains that form two functional catalytic 
sites. GC-C, -D, -E, and -F possess a carboxyl terminal tail that is not depicted here. sGCs 
are heterodimers possessing amino terminal regulatory domains containing a heme prosthetic 
group with a ferrous (Fe21) core that forms an imidazole axial bond with His105 of the b-
subunit. In addition, sGCs possess dimerization domains and carboxyl terminal catalytic 
domains that form one active and one inactive (flat blue) catalytic site. Colors identify domains 
with significant homology (Lucas et al., 2000, Guanylyl Cyclases and Signaling by Cyclic 
GMP. Pharmacol. Rev.52:375–413). 
 Α.1.1.2 Soluble GCs (sGC)  
The soluble guanylyl cyclases are expressed in the cytoplasm of nearly all 
mammalian cells and are involved in a wide variety of important physiological 
functions, such as preventing platelet aggregation, smooth muscle relaxation, 
vasodilatation, neurotransmission and immune-homeostasis. Composed of two 
subunits-a,-b, the expression of both is essential for the catalytic activity of the 
enzyme [2]. 
 
Α.1.1.2.1 Regulation of sGC by ligands 
 Nitrous Oxide (ΝΟ): It activates the sGC by binding directly to the heme ring. 
The CO has also the ability to bind directly to the heme but is a very weak 
activator of sGC compared to NO. 
 Protoporphyrin ΙΧ (PPIX): The protoporphyrin is a precursor molecule of 
heme and is associated with high affinity to sGC. 
 Divalent cations: Both pGC and sGC require divalent cations as substrate 
cofactors and allosteric regulators, in order to achieve the maximum catalytic 
activity of enzymes [2].  
Α.1.2  Action of cGMP 
The specificity of the cellular response of cGMP depends on the binding of cGMP at 
different protein targets. “Two evolutionarily distinct allosteric sites for binding cGMP 
are present in eukaryotic cells. One occurs with significant sequence homology in 
PKGs and cAMP-dependent protein kinase (PKA) and in the cyclic nucleotide-gated 
(CNG) cation channels, while the other occurs in cGMP regulated PDEs”, describes 
Lucas et al. in his review (2000) [2]. 
Α.1.2.1 cGMP dependent protein kinases 
The PKGs (protein kinases dependent on cGMP) are the main intermediates in 
facilitating the transmission of intracellular signals by cGMP. When the guanylyl 
cyclases are activated by different ligands, cGMP concentration increases. Then, the 
cGMP binds to PKGs, and activates them to phosphorylate their protein targets. 
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Finally, the phosphorylated proteins convert the extracellular stimuli in a particular 
biological function. In mammals two different genes for PKG have been identified. 
One of them is located on human chromosome 10 and encodes for the PKGI and the 
other one on chromosome 4 and encodes for the PKGII.  
The PKGI is a 76 kDa homodimer, strongly expressed in platelets, the cerebellum 
and in the smooth muscle cells. Through alternative splicing of the PKGI gene, two 
PKGI isoforms that differ in their N-terminal region and thus in the affinity for cGMP 
are produced, the PKGIα which is found mainly in thrombocytes, in the vascular 
system, kidneys and adrenal glands and PKGIβ which is found primarily in the 
uterus. Experiments with PKGI knockout mice as reviewed by Lucas et al. (2000) 
showed that, cyclic GMP induced relaxation in aortic rings or gastric fundus muscle 
strips prepared from PKG I deficient mice was impaired, whereas cAMP-induced 
relaxation was not. These mutant mice were hypertensive and lacked regular 
intestinal peristalsis, indicating PKG I is the specific mediator of cGMP effects in 
smooth muscles, in vivo. Furthermore, there was a defective cGMP-mediated 
inhibition of the activation response in platelets from the mutant mice, whereas 
cAMP-mediated inhibition was not impaired. Another experiment showed that these 
mice developed anemia and splenomegaly in 10 weeks after birth [9]. The anemia 
was probably due to the short life of erythrocytes, and the splenomegaly may be due 
to accumulation of red blood cell precursors due to the increased erythropoietin, 
response to anemia [2]. 
The PKGII is an 86 kDa membrane bound homodimer. It is absent from the 
cardiovascular system, abundant in brain and intestine, and is also expressed in 
lung, kidney, and bone. The only known substrate of PKGII is the CFTR channel 
(cysticfibrosis transmembrane conductance regulator), the phosphorylation of which 
leads to an increased secretion of chloride ions and water. The PKGII has less 
affinity for cGMP than the PKGI [2-9]. 
Α.1.2.2 Cyclic Nucleotides dependent ion channels  
The CNG channels contain a binding site for cGMP in the carboxyl terminal, like the 
one that cyclic nucleotide dependent protein kinases have. The main category of 
CNG channels regulates the entry of Na+, K+ in the cells. These channels are four-
domain proteins that "open" directly when cyclic nucleotides bind to them [2]. 
Α.1.3  Degradation of cGMP- dependent phosphodiesterases (PDEs) 
In order to stop the message in a signal transduction cascade through cGMP, the 
degradation of the original cGMP signal is of great importance. The 
phosphodiesterases degrade the signaling molecule cGMP, and thus they limit the 
time and spatial context of cGMP signaling.  
At least 10 different gene families encoding for phosphodiesterases have been 
identified in mammals. Each enzyme contains an evolutionarily conserved region of 
270 aa in the carboxyl terminus. “This domain cleaves the phosphodiester bond, 
hydrolyzing the 3’, 5’ cyclic monophosphate nucleotides to 5’ monophosphate 
nucleotides” describes Lucas et al., (2000). The various PDEs perform very 
specialized functions. The categories 1,2,3,10, hydrolyze both cAMP and cGMP. 
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While, the 4,7,8 only cAMP and the 5,6,9 only cGMP. The PDEs regulate heart 
function, steroid production in the adrenal glands, photo-transduction and also 
erectile response in males [2, 7]. 
Α.1.4 Motility of vascular smooth muscle  
The mechanism of vascular smooth muscle contraction as described by A. Lange 
(2006) is regulated by Ca2+ ions. During muscle contraction Ca2+ concentration is 
increased. Calcium levels can increase either by opening of the L-type calcium 
channels or by binding of hormones (noradrenaline, angiotensin II vasopresin, 
serotonin, endothelin I) to GPCR receptors. These (GPCRs) in turn activate the 
phospholipase C, which cleaves PIP2 into diacylglycerol (DAG) and inositol 
triphosphate (IP3). The IP3 increases calcium excretion from sarcoplasmic reticulum 
which activates the Ca2+ dependent, myosin light chain kinase. Through 
phosphorylaton of the myosin light chain a muscle contraction is achieved. It has 
been found that the phosphorylation of myosin light chain can be also done 
regardless of Ca2+, through the activation of the small GTPase RhoA, which activates 
the kinase of RhoA (ROK). In contrast during relaxation Ca2+ levels are reduced. This 
is achieved by increased cGMP or/and cAMP levels. Due to the reduction of calcium 
levels the activity of Ca2+-dependent myosin light chain kinase is reduced. In another 
pathway, the increased cGMP levels activate PKGI which in turn phosphorylates and 
activates the myosin light chain phosphatase. The phosphatase of myosin light chain 
dephosphorylates the myosin light chain and thus reduces the actin-myosin 
interaction which leads directly to muscle relaxation. Additionally, the IRAG protein 
(IP3-receptor-associated cGMP-dependent kinase-substrate) can be also 
phosphorylated by the PKGI. This protein is associated with the PIP3 receptor in the 
sarcoplasmic reticulum. Phosphorylation of IRAG leads to closure of the associated 
channels and results to decreased calcium levels facilitating thus muscle relaxation 
[2, 4].    
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Picture 2  
Molecular mechanisms underlying vascular smooth muscle relaxation mediated by cyclic 
GMP. Cyclic GMP induces smooth muscle relaxation by reducing [Ca
2+
]i and desensitizing the 
contractile apparatus to Ca2
+
. Cyclic GMP reduces [Ca
2+
]i by (1) inhibiting Ca
2+
 influx through 
L-type Ca
2+
 channels; (2) increasing Ca
2+
 efflux through activation of (2d) the Ca
2+
-pumping 
ATPase and (2b) the Na
+
/Ca
2+
 exchanger; also, cGMP may produce membrane 
hyperpolarization through activation of (2c) the Na
+
/K
+
 ATPase and (2a) K
+
 channels, thereby 
increasing Ca
2+
 extrusion by the Na
+
/Ca
2+
 exchanger; (3) increasing of Ca
2+
 sequestration 
through activation of the sarcoplasmic reticulum Ca
2+
-pumping ATPase [Ph, phospholamban]; 
and (4) decreasing of Ca
2+
 mobilization through inhibition of agonist-induced IP3 formation or 
inhibition of the IP3 receptor in the sarcoplasmic reticulum. R, receptor; G, G protein; PLC, 
phospholipase C; IP3R, IP3 receptor. Cyclic GMP desensitizes the contractile apparatus to 
Ca
2+
 (5) probably by activating myosin light chain phosphatase, resulting in 
dephosphorylation of the 20 kDa myosin light chain (Lucas et al., 2000, Guanylyl Cyclases 
and Signaling by Cyclic GMP. Pharmacol Rev 52:375–413). 
Α.1.5  cGMP: A Drug Target 
People with hypertension, hypercholesterolemia, nicotine consumption or diabetes 
mellitus have greatly increased risk for diseases of the vascular endothelium, i.e. 
situations in which blood vessels lose their elasticity and their ability to relax. This 
situation can lead by vasocontruction to ischemic diseases in both heart and the 
brain so that these cells can even die. In such situations of endothelial dysfunction 
vasodilatory substances such as NO, are being produced in less quantity. Even the 
production of anti-thrombotic agents such as the PGI2 is drastically reduced. After a 
disruption of the endothelium for example due to an inflammation, an increased 
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amount of LDL, thrombocytes and macrophages come to this area and create 
atheromatic plaques. The macrophages take in a big amount of LDL and become 
foam cells that secrete growth hormones. The smooth muscle cells proliferate and 
migrate in response to these hormones to other places creating thus atheromatic 
plaques. The blood swirls because of the plaques and causes mechanical rupture of 
blood vessels. To this point thrombocytes are activated and accumulate there while 
vasoconstriction helps to reduce blood loss. Often the creation of a large clot is 
favored so that the vessel is now completely closed, causing interruption of blood 
flow. Then we talk about myocardial infarction or stroke, regarding which organ lacks 
blood supply [4]. 
The therapeutic approach except for the administration of coagulant factors, also 
includes the use of nitrates (Nitroglycerine) which either by metabolism or not, will 
release NO in the blood, enough to cause vasodilation through a cGMP signaling 
mechanism as described above. 
Another disease example where the usage of cGMP targeting drugs has helped a lot 
is the erectile dysfunction. Indeed, the sildenafil selectively inhibits PDE5 in the 
corpus cavernosum leading thus to increased cGMP levels that induce blood vessel 
relaxation resulting to erection [7]. 
 
 
Picture 3 
Current concepts of cGMP signalling. cGMP generators (green) and effectors (red), as well as 
some downstream pathways and cellular functions (grey boxes) that are involved in the 
effects of endogenous cGMP and/or cGMP-elevating drugs (blue), are shown. The lower part 
shows some current (blue) as well as potential future (black) indications for drugs that 
modulate cGMP levels or cGMP effector pathways. BNP, B-type natriuretic peptide; cGKs, 
cGMPdependent protein kinases; IRAG, IP3 receptor-associated cGKIβ substrate; PDEs, 
phosphodiesterases; pGC, particulate guanylyl cyclase; sGC, soluble guanylyl cyclase;VASP, 
vasodilator-stimulated phosphoprotein (Robert  Feil et al., 2006, cGMP signaling: from bench 
to bedside. EMBO Reports 7, 149-153).  
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One can easily realize with a quick view at the introduction (and the literature), the 
great research interest at the cGMP field, because of its extensive involvement in 
many (patho-) physiological functions. Finding the way, how all these factors interact 
with each other, stimulates since decades the scientific interest. 
 
Α.2  Site Specific Recombination (SSR) 
Over the last decade site-specific recombinases-SSRs, such as Cre and Flp have 
become an essential tool for in vivo manipulation of the mouse genome. It is now 
possible to control the spatial and temporal initiation of a gene knockout in almost all 
tissues of the mouse leading thus to very "sophisticated" mouse models for human 
diseases and pharmacological research, explains Robert Feil (2007). SSR 
technology is also widely used for generating transgenic knockout models for cGMP 
signaling proteins such as the PKGI. Among other animal models, the mouse is 
preferred because of the plethora of genetic modifications that it can undergo and 
because of the quick way it breeds and develops in the laboratory. In addition to 
these so far it is the only organism for which there are embryonic stem cells available 
that can be used for gene targeting and production of transgenic models. The foreign 
DNA can be integrated at random positions within the mouse genome. This random 
integration is usually achieved by microinjection of the foreign DNA into the male 
pronucleus of a fertilized egg, but also other methods such as viral transfection to the 
oocyte or ES cell transfection are available. The random integration is mainly used 
for gene over-expression because the foreign DNA can be integrated in multiple 
copies in the mouse genome. Without any doubt this technique has provided a great 
deal of understanding in the gene function of mammals. But since the integration has 
been made in the germ line, this means that the foreign DNA is present in all body 
cells during animal’s life (total knockout model). For example, when a knockout is 
lethal for the embryo and therefore its contribution to the phenotype of the animal in 
later stages cannot be studied, or when we want to study the effect of a knockout at a 
particular stage in organism’s life or even large chromosomal rearrangements 
(deletions, duplications, translocations) the method mentioned above is not suitable. 
These restrictions have now been overcome with the site-specific recombination. The 
site-specific recombination is based on site-specific recombinases that can cut and 
paste DNA fragments between specific recognition sites and thus it is able one to 
generate specific changes in the genome of the organism [11-13].  
 
Α.2.1  Basic Principles of Site Specific Recombination 
Unlike homologous recombination that can occur between any two homologous 
sequences, site specific recombination is characterized by the mutual exchange of 
DNA fragments between two specific recognition sites and it is achieved by site-
specific recombinases. The necessary tools for the site specific recombination are a 
pair of specific recognition sites and a recombinase that recognizes these sites. The 
result depends on the position and orientation of the recognition sites [11].    
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Picture 4 
Basic principles of site-specific recombination as illustrated by the Cre/lox system.A The Cre 
recombinase (pacman) promotes reciprocal strand exchange between two 34-bp loxP target 
sites (triangles). Each loxP sequence consists of two 13-bp inverted repeats (horizontal 
arrows) flanking an 8-bp asymmetric spacer sequence that confers overall directionality. After 
binding of one Cre monomer to each inverted repeat, the DNA strands are cleaved in the 
spacer region (vertical arrows), exchanged between the two loxP sites, and ligated. The two 
half-sites of the loxP sequence that are recombined in a reciprocal manner are indicated by 
the black and white segments of the triangles and by bold and standard lettering. Note that 
the recombination reaction is conservative, i.e. it does not involve any net synthesis or loss of 
DNA so that two new functional loxP sites are generated. B Recombination between two loxP 
sites inserted into the same DNA molecule (intramolecular recombination) in opposite 
orientation leads to inversion of the intervening DNA segment. C Recombination between 
directly repeated loxP sites results in excision of the flanked DNA (circular product that is 
degraded) leaving one loxP site behind. When the loxP sites are located on separate DNA 
molecules (lower part), intermolecular recombination can lead to DNA integration. For kinetic 
reasons, DNA excision is strongly favoured over integration and, due to degradation of the 
circular product, can be considered irreversible. The dimensions of the white arrows indicate 
the relative efficiencies of the respective recombination reactions (Robert Feil, 2007, 
Conditional somatic mutagenesis in the mouse using site specific recombinases.  HEP 178:3–
28). 
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“In the 90s several laboratories around the world showed that a particular site-
specific recombination system, the Cre / lox system, works surprisingly well in the 
mouse and it can be used to generate tissue-specific and inducible knockout mice”, 
describes Robert Feil (2007).  
“The Cre recombinase (cyclization  recombination) is a 38 kDa protein encoded by 
the bacteriophage P1, which recombines the two 34-bp target sites on the P1 
genome called loxP (locus of crossing-over [X] of P1) without the need for any co-
factor” says Robert Feil (2007). The loxP sequence consists of two 13-bp inverted 
repeats flanking an 8-bp asymmetric spacer region that confers overall directionality. 
The Cre recombinase binds to the two inverted repeats of the loxP sites and 
catalyzes the excision of the intermediate fragment. On the other hand, the Flp 
recombinase (S. cerevisiae) recombines the part between two FRT sites, but with 
less efficiency, when compared to Cre [11]. 
Α.2.2  Genome Engineering strategies using SSRs 
“The basic strategy for SSR-directed genetic engineering is to insert the SSR 
recognition sites into the chromosomes, and then to deliver the SSR to recombine 
them as required”, mentions R. Feil in his review (2007). Then the recombinase 
recombines the fragment between the recognition sites. This technology allows 
genetic modifications in selected somatic cells. The most popular system for this 
purpose is the Cre / lox system and it is used to generate time-and tissue-specific 
knockout mice. The site specificity of Cre can be directed by Cre recombinases that 
are expressed in specific tissues only, while the time-specificity with ligand-activated 
Cre recombinases. Generally, a transgenic mouse is produced by mating a mouse 
carrying the loxP sites on both sides of the gene that will be knocked out, with 
another one which expresses the Cre recombinase selectively in a tissue. To 
generate a "flanked" mouse, the two loxP sites surrounding the gene of interest (that 
will be knocked out) are introduced by homologous recombination in ES cells. The 
ES cells are then cultured, selected and injected into blastocysts. These blastocysts 
are then introduced to a foster mother to develop to mice. For a Cre mouse, the 
integration of the Cre transgene downstream of a tissue-specific promoter is mainly 
achieved by random integration in the mouse genome. By crossing these two mice 
the flanked gene is excised in that particular tissue that expresses the Cre. Also, this 
system can be used to achieve large-scale chromosomal rearrangements. The 
precise control of Cre expression marks the success of the transgenic animal. One 
method to test the activity of Cre is to fuse it with the GFP or beta-galactosidase, so 
that it can quickly become clear whether the Cre is being produced or not. Another 
possibility is the LacZ Cre reporter mouse [18]. In this case a LacZ cassette is 
targeted into Rosa 26 locus (knock in) leading thus to ubiquitous expression of the 
LacZ gene construct. X-Gal staining is present in all cells where the Cre recombinase 
is expressed.  In every case though, Cre expression as well as the gene product 
should be also checked by molecular techniques [11].  
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Picture 5 
Generation of a tissue-specific knockout mouse. Two mouse lines are required, a floxed 
target mouse and a tissue-specific Cre mouse. The floxed target mouse (left) is generated by 
homologous recombination in ES cells. A popular strategy is to integrate a DNA construct that 
harbours three directly repeated loxP sites (triangles) flanking an essential exon (E) together 
with a selectable marker cassette (neo-tk) into the target locus, thereby generating a 
potentially hypomorphic tri-lox (L3) allele. The next step is to express Cre in the correctly 
targeted ES cell clones (or later in the respective mice) in order to convert the L3 allele by 
selective excision of the selection cassette to the conditional floxed (L2) allele. Note that 
complete excision generates a null (L1) allele that can be used as an alternative to a 
conventional gene knockout (see Fig. 2a). Whereas the neo gene (neomycin 
phosphotransferase) is used to select for ES cells that have integrated the DNA construct 
(positive selection with G418), the tk gene (herpes simplex virus thymidine kinase) is useful in 
the second step to select for cells that have undergone Cre-mediated excision of the neo-tk 
cassette (negative selection with ganciclovir). The tissue-specific Cre mouse (right) is in most 
cases generated by random integration of a cre transgene (containing a polyA signal 
sequence, pA) that is driven by a tissue-specific promoter (P spec.) to express Cre in the cell 
type of interest (shaded oval). Intercrossing of the floxed target mouse and the tissue-specific 
Cre mouse results in offspring (bottom) in which the floxed target exon is being excised in all 
Cre-expressing cells (shaded oval), thereby generating a tissue-specific knockout mouse (R. 
Feil, 2007, Conditional somatic mutagenesis in the mouse using site specific recombinases. 
HEP 178:3–28).  
 Picture 6  
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B Chromosomal translocation. By placing the loxP sites (triangles) on different chromosomes, 
chromosomal translocations with specific breakpoints can be created, for example, to model 
certain human cancers. Cre-mediated translocations are feasible between homologous or 
heterologous chromosomes. Note, however, that the efficiency of Cre-mediated 
interchromosomal rearrangements, in particular in the case of non homologous 
chromosomes, is fairly low, presumably reflecting chromosomal position within the cell during 
interphase and mitosis (R. Feil, 2007, Conditional somatic mutagenesis in the mouse using 
site specific recombinases. HEP 178:3–28). 
 
Α.2.3  Ligand-Activated SSRs 
“In many cases, tissue-specific genome modifications would be more informative if 
they could be induced at will at a chosen time during the life of the animal”, reviewed 
Robert Feil (2007). Thus potentially toxic effects of Cre could be avoided. The 
standard approach for the external control of the temporal onset of site specific 
recombination is to use ligand-dependent SSRs that can be selectively activated by 
synthetic drugs. The observation that the activity of a protein can be controlled by a 
ligand when it is fused to Ligand Binding Domain, LBD of the steroid hormone 
receptors led to the development of ligand activated-Cre recombinases (CreLBD). 
Further optimization of the technique leads to the CreLBDs that can respond only to 
synthetic ligands. Conjugation of Cre with a modified estrogen receptor (ER) can 
activate the Cre recombinase by the drug tamoxifen. In fact, in absence of the ligand, 
the chimeric Cre is located in the cytoplasm, whereas binding of ligand results in 
translocation of the Cre to the nucleus where it recombines the loxP-flanked DNA. 
The CreERT recombinase that can be activated by 4-hydroxytamoxifen but not by the 
endogenous β-estradiol, has been particularly useful for in vivo site-specific 
recombination uses. Of course, sometimes side effects can occur from high doses of 
tamoxifen. That is why several optimization modifications have been made to the 
original CreERT. Indeed, the CreERT2 is ten times more sensitive to tamoxifen than 
the initial CreERT. It is worth noting that the route of administration (dose, route, 
frequency) can significantly affect the recombination result and therefore they should 
be carefully determined before each experiment. Finally, other inducible systems 
such as tet-on and tet-off Cre system have been reviewed in literature, but there are 
significant drawbacks in these [11]. 
 
Picture 7 
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How do ligand-dependent Cre recombinases work? These recombinases are fusion proteins 
between Cre and the ligand-binding domains (LBDs) of steroid receptors. The LBD has been 
mutated so that it does not respond to its natural ligand yet binds a synthetic ligand. The 
scheme (left) illustrates the current model with the tamoxifen-activated CreER
T
 recombinase 
(modified pacman), a fusion of Cre with a mutated estrogen receptor (ER) LBD that responds 
specifically to the synthetic drug 4-hydroxytamoxifen (OHT) but not to β-estradiol. In the 
absence of OHT, the recombinase is located in the cytoplasm. Binding of OHT to the LBD 
results in the translocation of the recombinase into the nucleus where it can recombine its 
loxP substrates (triangles) (Robert Feil, 2007, Conditional somatic mutagenesis in the mouse 
using site specific recombinases. HEP 178:3–28).     
Α.2.4  Other Applications of genetic modified mice  
Transgenic mice have been shown to be very useful tools in drug research and 
human diseases research. Clearly one of the most powerful capabilities of the SSR 
technology is human cancer modeling. Indeed, one of the first applications of this 
technique was to delete and thus activate an oncogene in mice. Recently, the 
technique has been used to create chromosomal rearrangements (translocations) 
just like the ones that occur in many human cancers. The tracking of cell lineage is 
yet another application of SSR technology. It is now possible to track cells by coloring 
them, as the color is stable over a lot of proliferations or cell migration. It is then easy 
to scan for these cells and watch where they have migrated or settled. Another 
possibility is to make cells accumulate a radioactive substance which could be easily 
detected.  And then simply detect the radiation. The technique is very promising and 
it is believed that would help understand many human diseases such as metastasis 
in cancers or atherosclerosis etc [15, 16].  
Α.3  The cGi-500 sensor  
Due to the great importance of signaling through cGMP, is often required to monitor 
cGMP levels in real time. Until now, cGMP is being measured by RIA or ELISA in cell 
lysates, while another possible method is by using a cGMP antibody.  But the key 
problem is that the methods are not rapid and one has to fix the cells or the tissues. 
Moreover cGMP levels exhibit a maximum after stimulation with certain agents and 
then decrease so that it there is an urgent need for sensors that can record changes 
in time that they are actually happening and of course in living cells/tissues. 
So far, several attempts have been made to build such sensors. All of them consisted 
of an area where cGMP could bind (cGMP-binding domain), and of two different 
fluorescent proteins on each side, ECFP and EYFP. The new concept consisted of 
cGMP binding sites (either one: A, or two: A + B) taken from PDE5 and the PKGI. 
Regarding to the constructions with binding sites from PDE5, although they showed 
high affinity to cGMP, they exhibited extremely slow kinetics in binding and 
disassociation of cGMP at low concentrations. On the other hand, the constructions 
that contained two binding sites from PKGI (A + B cNMP BD), responded very 
quickly to changes in the concentration of cGMP and showed an 80% increase in 
emission ratio of CFP / YFP. Three sensors that were obtained with this technique 
were named based on their EC50. The cGi500: 500nM, cGi3000: 3μM, cGi6000: 6μM. 
These sensors showed fast cGMP binding and disassociation kinetics and high 
affinity for this molecule.  The function principle is that the EYFP and ECFP function 
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as a donor-acceptor pair for fluorescence resonance energy transfer (FRET), in 
which excitation of the donor (cyan) molecule at 436nm, leads to emission from the 
acceptor (yellow) molecule at 525nm, provided that the proteins are close enough 
(<10 nm) for energy transfer to occur. On the other hand when cGMP binds to the 
sensor its conformation changes (linear) so that the two fluorescent proteins are not 
close enough for FRET. In that case the excitation of the CFP at 436nm leads to 
emission of the same molecule at 475nm.  The sensor can be monitored with a dual 
emission fluorescent microscopy system recording for the CFP and the YFP (FRET) 
emission at the same time [14]. 
 
Picture 8 
Schematic representation of the cGi-500 sensor without (above) and with cGMP. In absence 
of cGMP the excitation of the donor (CFP) at 436 nm leads to an emission of the acceptor 
(YFP) at 525 nm (FRET). While when cGMP is bound to the sensor the excitation of the 
donor (CFP) at 436 nm leads to an emission from the same molecule at 475 nm (the pictures 
were drawn by Martin Thunemann). 
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Picture 9 
The above picture shows a schematic representation of the way this measuring procedure 
works. A light source at 436 nm excites the sample, which in turn emits light at 475 nm (CFP) 
or/and at 525 nm (FRET) because it consists of sensors with and without cGMP respectively. 
A dual recording system records both colors which are then analyzed by a computer. A CFP 
signal indicates sensors with cGMP bound on them, whereas a FRET signal denotes sensors 
without cGMP bound on them (the pictures were drawn by Martin Thunemann). 
  
 Picture 10 
The diagram (pic. 10) results after cGMP measurements with the sensor. After a particular 
time (e.g. 1050 sec) a drug that has been administrated to the cells increases the intracellular 
cGMP. This leads to conformational changes to the sensor altering thus the emission pattern. 
The CFP signal increases (cGMP binds to the sensors) while the FRET signal reduces (fewer 
sensors without any cGMP bound to them) [Martin Thunemann, personal communication].    
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Α.4  The Rosa26mT/mG plasmid 
“So far dozens of different Cre mice have been created, each of them requires 
careful characterization of spatial and temporal expression of Cre”, as describes 
Mandar Deepak Muzumdar (2007). Not only that, but “also questions of great 
biological interest such as those concerning cell morphology and cell lineage tracing 
are only a few of the examples, why such a reporter system is needed” explains 
Martin Thunemann. For this purpose specific transgenic mice have been constructed 
so that they will express a particular marker (LacZ, GFP, CFP or YFP) after Cre 
recombination. But in order to assess the number of tissues in which Cre is active, a 
double-labeling system for cells is important. For example expression of a marker 
(LacZ) prior to Cre recombination and another different marker (GFP) after Cre 
recombination. In contrast to the older systems, a double fluorescent reporter could 
allow the visualization of non-recombined and recombined cells without using any 
exogenous enzyme substrate. While the green fluorescent protein GFP was used 
since decades in biological research, a newly introduced red fluorescent protein 
(RFP) had not gained ground because of the toxicity that caused. Recently, a great 
number of new red fluorescent protein variants were developed to overcome the 
existing problem. One of them, the tandem dimmer Tomato (tdTomato) was 
particularly selected for its outstanding brightness and the photostability and because 
it also showed reduced toxicity [1].  
By combining the two fluorescent proteins came of a new Cre double fluorescent 
indicator, the mT/mG. This indicator is a membrane-targeted version of the tdTomato 
surrounded by two loxP sites, followed by a membrane-targeted GFP (downstream of 
the strong CAG promoter (β -actin, and the enhancer of CMV) [17]. All the mice 
generated with the above construct, expressed the mT protein, while all Cre 
recombined cells were mG positive. The cassette was targeted into Rosa26 locus (6th 
chromosome), as this is expressed in all cells, without falling into heterochromatin. 
Although the endogenous Rosa promoter is not so strong, the CAG promoter 
targeted into Rosa26 locus results in high expression levels of the double reporter 
transgene. Furthermore, homozygous and heterozygous knock-in mice are viable, 
fertile and without any phenotypic changes [1]. 
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Picture 11 
 
1. Ubiquitous mT labeling in mT/mG mice prior to recombination. (a) Live whole mount 
and fixed tissue sections of various organs from an adult mT/mG mouse 
demonstrating ubiquitous mT labeling. (b) Examples of individual live mT-labeled 
cultured neurons derived from embryonic cortical caps of mT/mG mice. (c) mT/mG 
cerebella and olfactory bulb glomeruli reveal no difference in mT fluorescence 
between mice at 12 versus 42 weeks of age. Scale bars: (a) 200 lm, (b) 50 lm, (c) 
200 lm. (Muzumdar et al., 2007,  A Global Double-Fluorescent Cre Reporter Mouse. 
genesis 45:593–605) 
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Picture 12 
mG labeling in mT/mG mice after Cre-mediated recombination. (a) Live whole mount and 
fixed tissue sections of various organs from an adult mT/mG;hprt-Cre mouse demonstrating 
global mG labeling. Images represent composite of red and green channels, indicating 
minimal red fluorescence. (Muzumdar et al., 2007, A Global Double-Fluorescent Cre Reporter 
Mouse.  genesis 45:593–605) 
Α.5  Aim of this work and strategy    
In this project we used the plasmid Rosa26mT/mG [1] as a starting point to generate 
a targeting vector with a Multiple Cloning Site, where it could be sub-cloned any gene 
of interest. The main reason was the strong CAG promoter (CMV enhancer +chicken 
β-actin promoter) that drives high level expression of the transgene and also the fact 
that this targeting vector has been successfully used to generate a well working 
‘mouse line’ (see § A.4).The process involved the excision of the mG fragment from 
the Rosa26mT/mG plasmid and then its replacement by a MCS. In order to manage 
this, the mG fragment should be removed by the enzymes HindIII/EcoRI, something 
that was not possible, as these enzymes cut several times in the homologous 
recombination arms, so that the original targeting vector was cut into small pieces. 
Therefore, the primary targeting vector was digested with AscI/PacI and the fragment 
containing the CAG promoter, the loxP-mT-loxP, the mG, and the FRT-Neo-FRT (7,2 
kb) was sub-cloned into a small plasmid vector constructed for this purpose, 
(pLinker3 2,6 kb) based on pUC19. From then on it was possible to isolate the mG by 
HindIII/EcoRI and replaced it by a MCS that contained unique restriction enzyme 
sites in the whole targeting vector. Then the MCS containing fragment was cloned 
again back to the original targeting vector. In the MCS we sub-cloned the thymidine 
kinase (sr39tk) and the cGi500 sensor. Additionally some smaller plasmids 
containing the CAG promoter, the floxed mT and the MCS were generated for 
expression in eukaryotic cells. 
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Β. Materials and Methods 
Β.1  Materials 
Β.1.1  Chemicals  
Bovine Serum Albumin (BSA)                                                          Roth 
Chloroform (CHCl3)                                                                                              Roth 
EDTA                                                                                                                  Roth 
HCl                                                                                                                   Roth 
HEPES                                                                                                      Roth 
LB Agar                                                                                                       Roth 
LB Broth                                                                                                      Roth 
NaCl                                                                                                                  Roth 
NaHCO3                                                                                                      Roth 
NaOH                                                                                                                   Roth 
SDS (Sodium dodecyl sulfate)                                                                    Roth 
Tris                                                                                                                       Roth 
Agarose                                                                                                    Biozym 
Ethanol (EtOH)                                                                                          VWR 
Ethidium Bromide (EtBr)                                                                                      Roth 
Glucerol                                                                                                               Roth 
Isopropanol                                                                                                         Roth 
Sodium acetate                                                                                                   Roth 
Phenol:Chloroform:Isoamylalcohol  25:24:1                                          Roth 
                               
 
 
 
 
 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 04:38:13 EET - 137.108.70.7
24 
 
Β.1.2  Enzymes 
Β.1.2.1  Restriction Enzymes 
Enzyme     Provider 
AscI 
  
NEB 
AseI 
  
NEB 
AsiSI 
  
NEB 
BamHI 
  
NEB 
BspEI 
  
NEB 
EcoRI 
  
NEB 
EcoRV 
  
NEB 
FseI 
  
NEB 
HindIII 
  
NEB 
Kpn2I 
  
Fermentas 
MluI 
  
NEB 
NcoI 
  
NEB 
NdeI 
  
NEB 
NheI 
  
NEB 
NotI 
  
NEB 
PacI 
  
NEB 
ScaI 
  
NEB 
XbaI 
  
NEB 
XhoI 
  
NEB 
XmaI 
  
NEB 
     
Β.1.2.2  DNA/RNA modifying enzymes 
Enzyme     Provider 
Antarctic Phosphatase NEB 
CIP 
  
NEB 
RNAase 
  
ROTH 
T4-DNA Ligase 
 
NEB 
T4-Polynucleotide Kinase  NEB 
   
Β.1.3  Buffers 
Β.1.3.1  DNA isolation Solutions 
S1 (Resuspension Buffer) 
50 mM Tris-HCl 
 10 mM EDTA 
 100 μg/ml RNAase 
 pH=8,0 
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S2 (Lysis Buffer) 
200 mM NaOH 
1% SDS 
  
S3 (Neutralization Buffer) 
2,8 M KΑc 
 pH=5,5 
   
N2 (Column Equilibration Buffer) 
100 mM Tris 
  15% EtOH 
  900 mM KCl 
  0,15% Triton X-100 
 pH=6,3 (H3PO4) 
   
 
  N3 (Washing Buffer) 
100 mM Tris 
 15% EtOH 
 1,15 M KCl  
 pH=6,3 (H3PO4) 
  
N5 (Elution Buffer) 
100 mM Tris 
 15% EtOH 
 1,0 M KCl  
 pH=8,5 (H3PO4) 
  
 
Β.1.3.2  Cell Culture Buffers  
PBS       
 135 mM NaCl 
 
4 g 
 3 mM KCl 
 
100 mg 
 8 mM Na2HPO4 x 2H2O 710 mg 
 2 mM KH2PO4 
 
120 mg 
 Ad to 500 ml H2O 
 pH=7,4 (NaOH), autoclave 
     Trypsin       
 9 parts PBS  
   1 part 10x Trypsin/EDTA (Invitrogen) 
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DMEM          
Dulbeco's Modified Eagle Medium  
 (Invitrogen) 
   GlutamaxI ™ (Dipeptide L-Alanyl-L-Glutamin) 
4500 mg/l D-Glucose+ Sodiumpyruvate 
     100x  Penicillin/Streptomycin 
  invitrogen, 10.000U/ml/ 10.000U/μg/ml 
 
     DMSO  Dimethylsulfoxid 
   
Β.1.3.3  LB-Agar 
Weight 35 g/L. Autoclave before use 
Β.1.3.4.1 LB-Medium 
Weight 20 g/L. Autoclave before use 
Β.1.3.4.2  1x ΤΒΕ Buffer  
For 1 L 1xTBE Buffer:  
10,8 g (89 mM) TRIS  
5,5 g (89 mM) Boric Acid 
0,7 g (2 mM) EDTA-Na2 
 
 Β.1.3.4.3  6x Gel Loading Buffer  
30% Glycerol 
 0,05% Bromophonolblue 
0,05% Xylencyanol  dH2O to 10ml 
 
 
B.1.3.5 Antibiotics (Ampicillin) 
Add 1 g Ampicillin in 10 ml dH2O and filtrate to sterilize 
 
Β.1.4  Synthetic Oligonucleotides 
Β.1.4.1  Sequencing Primmers 
MH15: GTAGCGGCTGAAGCACTGCAC 
M13uni (-43): AGGGTTTTCCCAGTCACGACGTT 
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Β.1.4.2  Oligonucleotides used for cloning 
For pLinker5 construction:  
                                            |HindIII|              |EcoRI|              |  AsiSI    |      
          |   FseI    |      |NcoI  |              |BamHI|              | MluI  | 
aattggccggccagccatggaagcttggatccgaattcacgcgtgcgatcgc 
ccggccggtcggtaccttcgaacctaggcttaagtgcgcacgctagcgtcga 
 
For Multiple Cloning Site (MCS) construction:  
                         |XmaI  |                                   | MluI  |                  
            |     FseI  |                            | AsiSI     | 
ccggaggccggcccgggtatcagtggcgatcgcacgcgtc 
tccggccgggcccatagtcaccgctagcgtgcgcagagct 
 
Β.1.5  Bacteria 
We used the E.coli XL1- Blue.  
XL1-Blue Genotype: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB 
lacIqZΔM15 Tn10 (Tetr)]. 
B.1.6   1 kb Ladder  
0.9% agarose gel 
Stained with ethidium bromide  
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Methods 
Β.2  Molecular Biology Methods 
(Obtained from the diploma thesis of  Matthias Hillenbrand:  “Herstellung und Charakterisierung 
Rekombinanter Bakulloviren für Biochemische Untersuchungen an der cGMP –abhängigen Protein 
Kinase„ ,Tübingen, Dec. 2007) 
Β.2.1 Nucleic Acids Quantification  
Β.2.1.1 Photometric assessment  of Nucleic Acids concentration 
Determining the concentration of nucleic acids by measuring the optical density (OD) 
is a quick and easy method, however due to the requirement in big quantities of 
nucleic acid is mainly used in nucleic acids found in big quantities (maxi-prep) and 
pure oligonucleotides. 
The spectrophotometer is blanked with 990μl dH2O in a clean cuvette. Then 10 μl of 
the solution of the nucleic acid is added. The optical density is measured at 260 nm 
(for DNA). 1 OD260nm equals to 50 μg/ml dsDNA and 33 μg/ml oligonucleotide. The 
average of two measurements is then multiplied by 50*100 (dilution) and the result is 
in ng/μl. A sample purity indication is the OD260nm / OD280nm ratio. A value between 1.7 
and 2 indicates that the sample is free of proteins. 
 
Β.2.1.2 Gel Agarose Quantification.   
This method though not highly accurate offers a quick idea of the concentration of a 
nucleic acid in a sample. For this purpose a small amount of a sample is loaded (or 
different aliquots of a sample) in an Agarose Gel, and the thickness of the bands 
obtained is compared with known concentration of DNA bands or the bands of the 
molecular weight marker. 
Β.2.2 Oligonucleotides  
It is possible to synthesize oligonucleotides that are going to be used as primers in a 
PCR or as an insert in a cloning strategy. These oligonucleotides are delivered by 
each biotech company (in this case: MWG Biotech Ebersberg) in a lyophilized form 
that should be diluted with dH2O to a final concentration of 100 pmol/μl. Because the 
oligonucleotides are synthetically prepared, they lack 5 'phosphate group, which 
must be added enzymatically if they are going to be used as inserts for cloning. 
 
Β.2.3  Enzymatic Manipulation of DNA.  
Β.2.3.1 Phosphorylation of 5’ ends of oligonucleotides 
The 5’ phosphate group of a DNA molecule is essential for a successful cloning. The 
following protocol describes the addition of a phosphate group in two complementary 
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oligonucleotides in a reaction and ensures the correct final configuration of the 
double helix. 
1. For an End volume of 20 μl: 
       1 μl Oligonucleotide Α (100 pmol/μl)  
1 μl Oligonucleotide Β (100 pmol/μl)  
2 μl 10x PNK-Buffer (NEB)  
15 μl dH2O  
1 μl Τ4-Polynucleotide Kinase (100 u/μl; ΝΕΒ)  
2. Incubate 90 min at room temperature 
3. Incubate at 75 οC, in a beaker with water for 10 min, in order to denature 
wrong complementarities and to inactivate Τ4-polynucleotide kinase 
4. Allow the beaker with the eppendorf tubes inside to cool down slowly at 4 
οC, while stirring all the time. In this way, an optimal hybridization of two 
complementary strands is achieved 
5. Add 180 μl dH2O (dilution 1:10).The oligonucleotides are ready for use in 
ligation 
 
Β.2.3.2  Digestion of DNA with Restriction Enzymes 
Type II restriction endonucleases allow to molecular biologists to cut DNA at specific 
sites and thus to ligate two DNA segments (by the enzyme T4-DNA Ligase) that have 
been cut with the same restriction enzyme. Regarding the restriction enzymes, there 
are enzymes that cut the DNA resulting to sticky ends or blunt ends. The ends 
resulting from the digestions with these restriction enzymes have a 5'-phosphate or 
3'-OH group, and so they do not require incubation with any kinase before further 
use.  According to the purpose, it is possible to make analytical or preparative 
reactions.  
1. In an eppendorf tube pipette together:  
 
Analytical Reaction   Preparative reaction   
 χ μl DNA (200 ng)   
 
 χ μl DNA (20 μg)   
  2 μl 10x reaction buffer (+BSA) 10 μl 10x reaction buffer + BSA 
 0,5 μl Enzyme (5U) 2 μl Enzyme (10U) 
Add to 20 μl dH2O Add to 100 μl dH2O   
 
(Negative controls without the enzyme must not be forgotten) 
2. Incubate at the right temperature (usually at 37 oC) according to the provider 
for 1 h or overnight. 
3. To control the reaction 100-200ng DNA are loaded on an agarose Gel. 
 
Β.2.3.3  Dephosphorylation of 5’ ends. 
If a plasmid is going to be used as a vector for some DNA-insert, and it is cut in such 
a way (especially for cases resulting in blunt ends) that a lot of relegation of the 
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vector will take place, resulting in many false clones, then the vector must be 
dephosphorylated before the ligation. 
1. In a fully digested preparative reaction, (Β.2.3.2) add 1μl (10U) CIP (NEB: 
‘calf intestinal alkaline phosphatase) and incubate for 1 h at 37ο C. 
2. Inactivate the CIP by incubating for 10 min at 75 οC. Storage of the sample 
can be done at -20 οC or it can be directly used for a preparative Gel 
electrophoresis (Gel with big ‘wells’ in order to isolate then the desired band).  
 
Β.2.3.4  Ligation of DNA fragments with the Τ4-DNA-ligase 
The ligation of DNA fragments using T4-DNA-ligase is a key point in the construction 
of new plasmids. The T4-DNA-Ligase uses ATP to join a free 5'-phosphate group 
with a free 3'-OH group of two double stranded DNA molecules. This is the way to 
ligate DNA fragments with sticky or blunt ends. In the second case though (with blunt 
ends) with less success.  
The concentration of the vector (dephosphorylated) and the insert, can be easily 
estimated with an Agarose Gel (B.2.1.2). In the ligation reactions the ratio vector/ 
DNA insert should be about 1:2 to 1:5. 
 Β.2.3.4.1 Protocol for sticky ends 
1. The ligation reactions are prepared according to the table below (always use 
the vector relegation as a control) 
              
 χ μl DNA-vector(100-300 ng)   
     χ μl DNA-insert (200-1500 ng)   
   2 μl 10x Τ4-DNA Ligase buffer  
    Add to 19 μl dH2O 
    5 min at 50 οC 
     Cool down at room temperature 
   add 1 μl T4-DNA Ligase (400U/μl; ΝΕΒ, for sticky ends) 
2. Incubate over night at 12-14 οC. 
3. 5 μl from each ligation reaction are loaded on an agarose gel just to control 
the ligation. The rest is precipitated and prepared for electroporation. 
 
Β.2.4  Electrophoresis Methods 
Β.2.4.1  Agarose Gel  
The Gel electrophoresis is the most easy and effective method for separating DNA 
molecules of different sizes. The principle of the method is based on the fact that a 
charged molecule will move when placed in an electric field. The speed (u) depends 
on the charge of the molecule (z), the intensity of electric field (E), and the coefficient 
of friction (f). 
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U=  
The coefficient of friction depends on the mass and shape of the molecule (circular or 
linear DNA) and the viscosity of the medium (agarose). Small molecules move faster 
than larger molecules. More specifically, the method includes the preparation of 
various agarose gels (% w/v) depending on the expected size of the DNA molecules 
to be electrophorated. For molecules > 1kb an agarose gel of 0,8% is enough, while 
for molecules <1kb a 2% agarose gel is needed. In the gel we add a small quantity of 
ethidium bromide (EtBr), a substance that binds strongly to the double-stranded DNA 
and has the ability to emit an orange color when it is viewed under the ultraviolet 
light. The length of the DNA sample can be accurately estimated by comparing the 
bands with a DNA of a known length (1 kb DNA Ladder). The process of making 100 
ml (e.g. 0.8%) agarose gel is summarized below: 
 0,8 g  agarose (LE Agaroze, Biozym) 
    100 ml TBE buffer 
      Heat in order agarose to dissolve 
    5 μl EtBr (5 μl/100 ml) 
     stirring 
 
     
When the mixture has cooled down, it is poured into a special device that will give the 
right shape to gel. Samples are loaded in the wells, after adding the 6x Gel Loading 
buffer. Samples are allowed to run at 80-130 volt power for 1h or more, always 
depending on the length of the DNA. 
B.2.4.2   Analytical Agarose Gel 
For an analytical agarose gel we used agarose gels with small 'wells' (4mm). The 
DNA is mixed with an appropriate amount of gel loading buffer, and then loaded into 
the wells and allowed to run at low voltage for at least 1h. 
Β.2.4.3  Preparative  Agarose Gel   
For a preparative agarose gel, are used agarose gels with big 'wells' (22mm). A 
preparative reaction (B.2.3.2) is loaded into the big wells (1-4), so that it could be 
then easily to cut out the desired band without the risk of contamination from 
undigested DNA or other unwanted bands. In addition, in order to reduce the risk of 
contamination from previous runs, it is advised to clean the device before use, as 
well as adding new 1x TBE buffer. Using a clean scalpel, the desired band is cut out 
under the ultraviolet light. Attention and rapid movements are required to limit 
prolonged exposure of the DNA under the UV light, avoiding thus the formation of 
thymine dimmers. To minimize DNA mutations, one is strongly advised to adjust the 
UV device (312nm) at 70%. The isolated piece of agarose can be then used in 
electro-elution to gain the desired DNA out of it.   
 
 
f
Ez
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Β.2.4.4 Electro elution of DNA fragments 
The electro-elution is an efficient and DNA size-independent method for isolating 
DNA from agarose pieces. The disadvantage lies in the fact that it is a quite time 
consuming method. The procedure is described below: 
1. A Dialysis bag (6-10 cm) that has been boiled 2 times in a 10 mM EDTA, 
pH=8 solution, is washed initially with some H2O. One of the sides is 
clammed so that the content cannot escape. 
2. Τhe agarose piece that has been excised from the gel is being inserted in the 
bag. 1-2 ml 1x TBE buffer is added. The other end is also secured. Always 
avoid bubbles in the bag and try to put the agarose piece as closely to the 
one side of the bag as possible.   
3. The dialysis bag is then placed horizontally on an agarose gel electrophoresis 
device and 1x TBE buffer is added as well. 
4. Let it run for about 1h at 80-100 volt. 
5. Under the UV light (70%) testify, if the DNA has been eluted out of the 
agarose piece. The polarity is then changed for 30 sec, so that the DNA can 
come off the bag walls. 
6. The Dialysis bag is opened carefully from one side and the content is 
transferred in a clean eppendorf tube. 
7. A brief centrifugation is advised in order to precipitate any agarose little 
pieces. 
8. The supernatant is collected in a new eppendorf tube and it can be used 
directly for ligation or it can be cleaned with phenol/chloroform.   
9. A small amount of the supernatant is often loaded on an analytical gel 
electrophoresis in order to estimate its purity and concentration. 
 
Β.2.5  Precipitation, concentration and phenol/chloroform cleaning of DNA 
Many times in molecular biology is required the concentration or removal of annoying 
substances such as: salts from a solution of DNA. In this case the choice is 
precipitation with ethanol or isopropanol. Should be needed a high purity DNA free of 
proteins such as histones, then cleaning with phenol-chloroform is the choice. 
 
Β.2.5.1  Ethanol precipitation protocol 
1. Add 1/10 of the sample volume 3 Μ sodium acetate pH=5,5 and 3 volumes 
100% cold (-20 οC) ethanol 
2. Incubate at least for 1h at -80 οC 
3. Centrifuge at 13000 rpm for 15-20 min in a cooling centrifuge 4 οC 
4. The supernatant is thrown away and same volume of cold 70% ethanol  is 
added to wash the pellet 
5. Centrifuge at 13000 rpm for 15-20 min in a cooling centrifuge 4 οC 
6. Throw away the supernatant (Note: Pellet can be washed more than once) 
7. Dry the pellet and re-suspend it in 20 μl dH2O 
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B.2.5.2   Protocol for precipitation of ligation reactions  
1. To inactivate Τ4-DNA-ligase (Β.2.3.4.1), incubate at 65 οC for 15 min 
2. Add to 50 μl dH2O  
3. Add 5 μl of 3 Μ pH=5,5 sodium acetate as well as 1 μl tRNA (1 μg/μl) to 
increase the nucleic acid concentration 
4. add 150 μl 100% cold (-20 οC) ethanol 
5. Incubate for at least 1h at -80 οC 
6. Centrifuge at 13000 rpm for 15-20 min in a cooling centrifuge 4 οC 
7. Throw away the supernatant and add 200 μl cold 70% ethanol to wash the 
pellet  
8. Centrifuge at 13000 rpm for 15-20 min in a cooling centrifuge 4 οC 
9. Throw away the supernatant 
10. Dry the pellet and re-suspend it in 20 μl dH2O 
 
To control the ligation reaction and the precipitation is strongly advised to run an 
analytical gel electrophoresis with 5 μl of each ligation reaction. 
 
B.2.5.3 Phenol/Chloroform cleaning protocol 
1. Add the same volume of phenol 
2. Centrifuge at 13000 rpm for 15 min in a cooling 4 οC 
3. Collect the supernatant in a clean eppendorf tube (Note: leave a small 
amount of supernatant especially near the two phases line) 
4. Add the same volume of chloroform 
5. Centrifuge at 13000 rpm for 15 min in a cooling centrifuge at 4 οC 
6. Collect the supernatant in a clean eppendorf tube (Note: leave a small 
amount of supernatant especially near the two phases line) 
 
The collected DNA can be precipitated with ethanol or isopropanol as described 
above. To precipitate with isopropanol the steps below are followed: 
 
For 1 ml collected supernatant: 
1. Add 100 μl sodium acetate 3 Μ pH=5,5 and 900 μl isopropanol 
2. Incubate at least 1h at 4 οC 
3. Centrifuge at 13000 rpm for 15-20 min in a cooling centrifuge 4 οC 
4. Throw away the supernatant and add 1 ml 70% cold ethanol to wash the 
pellet  
5. Centrifuge at 13000 rpm for 15-20 min in a cooling centrifuge 4 οC 
6. Throw away the supernatant 
7. Dry the pellet and re-suspend it in 20 μl dH2O 
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Β.2.6  Bacteria Transformation through electroporation  
One of the best and easiest methods to introduce foreign DNA into bacteria is the 
electroporation. The transformation efficiency is about 107-109 colonies per 
microgram pUC18. For the electroporation, bacteria free of salts and a salt-free DNA 
solution is required. The bacteria are put together with the DNA solution in a fresh 
electroporation cuvette (electrode distance of 0,2 cm, BioRad) and they are exposed 
to a short electric pulse. This leads to formation of small pores in the bacterial cell 
membrane, so that they are able to take up exogenous DNA. A key factor for the 
success of electroporation is to work with solutions and bacteria free of ions. Ions 
create an electric current in the cuvette which results in sparks and warming that 
finally 'bake' the bacteria. The device: 'Gene Pulser XCell ™ Electroporation System' 
(Biorad) has been used for the electroporation.  
Β.2.6.1  Electroporation (E.coli  XL1-Blue) 
1. 100 μl of competent cells are thawed in ice, and mixed with 15 μl of the 
precipitated ligation reaction (Β.2.5.2) 
2. Keep the electroporation cuvettes and  the cells/ligation mixture on ice for 5 
min  
3. Add the cells/ligation reaction mixture in the cuvette avoiding bubble formation 
4. Electroporate using the settings bellow: 
 Voltage: 2,5 kV 
 Capacity: 25μF 
 Resistance: 200 Ω 
  Tc should be between 4-5 msec 
5. Add 900 μl LB-Medium without any antibiotics immediately after 
electroporation to allow cells to recover. Transfer the cells in a new 15 ml 
falcon and incubate for 1h at 37 οC at 225 rpm  
6. Plate the bacteria on LB-Agar +Amp petri dishes and incubate at 37 οC over 
night (Plate 10, 100 and 300 μl of bacteria) 
7. The next day count the bacterial clones and estimate the transformation 
efficiency 
 
Note: Always electroporate the vector religation reaction. The bacterial clones then 
should be much less on these plates, than on the ligation plates.  
 
Β.2.7  Plasmid DNA isolation 
Β.2.7.1  Plasmid DNA isolation from mini-preps 
Plasmid DNA isolation from bacteria on a small scale (mini-preps) is usually 
combined with an analytical digestion with restriction enzymes (B.2.3.2), due to the 
rapid results and it is used to identify positive bacterial clones, namely bacterial 
clones carrying the desired plasmid after electroporation. It is based on alkaline lysis 
of bacterial cells by Birnboim and Doly (1979). Lysis of the bacterial cells is achieved 
with a NaOH/SDS solution, that denatures protein molecules and DNAs. After 
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neutralization with potassium acetate, the double stranded plasmid DNA can re-
nature and gain its native supercoiled structure, something that can’t happen with the 
bacterial genomic DNA, which is then precipitated along with other cellular 
components. 
1. A unique bacterial clone is inoculated in 5 ml LB-Medium +Amp and 
incubated at 37 οC overnight under constant stirring at 225 rpm 
2. 1 ml of this culture is transferred into 2 ml eppendorf tubes and centrifuged at 
5000 rpm at 4 οC for 5 min. The rest 4 ml are stored at 4 οC in order to 
inoculate a maxi-prep 
3. The supernatant is thrown away and the bacterial pellet is re-suspended in 
100 μl S1 buffer which contains RNAase (1/100 diluted) 
4. Add 200 μl S2 buffer and mix carefully (not vortexing) 
5. Add 150 μl cold (4 οC) S3 buffer, as well as 50 μl chloroform, which pellets 
better the neutralization buffer. Incubate on ice for 5 min 
6. Centrifuge for 15 min at 4 οC at 13000 rpm (insoluble cellular components as 
well as the genomic DNA are precipitated as a pellet, while the plasmid DNA 
remains in the supernatant) 
7. Transfer the supernatant in a new eppendorf tube and add 1 ml 100% cold 
ethanol (-20 οC) 
8. Centrifugation for 15 min at 4 οC at 13000 rpm 
9. Throw away the supernatant and add 1 ml 70% cold ethanol (-20 ο C) to wash 
the pellet (Note: pellet washing can be done more that once) 
10. Centrifugation for 15 min at 4 οC at 13000 rpm 
11. Throw away the supernatant and dry the pellet.  
12. Add 20 μl dH2O to re-suspend the pellet 
 
5 μl are enough for an analytical digestion with restriction enzymes. The remaining 
solution can be stored at-20 °C for any future use. 
 
Β.2.7.2  Plasmid DNA  isolation from maxi-preps 
For high purity plasmid DNA in large scale (500 ml culture), bacteria are lysed by 
alkaline Lysis just as in mini-preps. In this case though, the plasmid DNA is not 
gained by precipitation with ethanol, but through an anion-exchange column. 
Columns used: Nucleobond AX 500, Company: Macherey-Nagel. 
1. The rest 4 ml from the other day culture are used to inoculate a large scale 
culture (500 ml).  
2. Harvest the bacteria by centrifugation at  4 οC, 5000 rpm, for 15 min 
3. Re-suspend the bacterial pellet in 12 ml S1 buffer + RNAase 
4. Add 12 ml S2 buffer  
5. Add 12 ml S3 buffer  
6. Incubate on ice for 5 min 
7. Wet the filter and equilibrate the column with 6 ml Ν2 buffer  
8. Load the bacterial lysate into the filter 
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9. When the whole lysate has been through the column take out the funnel, and 
wash the column with 32 ml N3 buffer  
10. Elute the DNA with 15 ml N5 buffer and collect it in a new 50 ml  falcon   
11. Precipitate with 11 ml of isopropanol. Centrifuge at 4 οC, 5000 rpm, for about 
30 min. Throw away the supernatant 
12. Add 5 ml 70% cold ethanol (-20 οC) and centrifuge at 4 οC, 5000 rpm, for 20-
25 min 
13. Throw away the supernatant and dry the pellet 
14. Re-suspend the pellet in 200 μl dH2O and determine the concentration by 
spectrophotometer measurement (Β.2.1.1). Dilute with dH2O to adjust to the 
standard concentration of 1 μg/μl (if it is necessary) 
15. The DNA can be stored at -20 οC 
 
Β.2.8  Characterization of recombinant plasmids 
To characterize potential recombinant plasmids that have been isolated using the 
above procedures, analytical digestions are carried out. Using bio-informatics  
(Vector NTI, Invitrogen) it is easy to calculate the fragment lengths resulting after 
digestion with specific restriction enzymes. An analytical gel electrophoresis confirms 
the presence or absence of these fragments. Alternatively, samples can be also sent 
for sequencing in several biotech companies. 
 
Β.2.8.1  Plasmid DNA sequencing 
The sequencing takes place in the biotechnological company MWG Biotech 
(Ebersberg) by the Dideoxy-ribonucleotide method of (Sanger, 1977). Depending on 
the plasmid purity and the primer that has been chosen, the sequencer can read 
approximately 1000 bp. The DNA sample can be pre-mixed with a desired primer, or 
the company can be asked to use a standard primer. The sequencing results are 
sent within a few days to the recipient by email. The samples were sent as bellow:  1 
μg DNA in 15 μl dH2O. Samples sent for sequencing: ploxP-MCS-pA (primer: 
M13uni), pLinker5 (primer: M13uni), pmT/cGi500 (primer: MH15), pL5-cGi500 
(primer: M13uni).   
 
Β.3  Cell Culture Methods  
Β.3.1  Cell Trypsinization and passaging 
1. The cells are washed 2 times with PBS and then some drops of trypsin are 
added to them (for 6-well plates/ pro well). The cells are then incubated for 5-
10 min at 37 οC and are observed under the microscope to see if they have 
been detached from the flask 
2. Add 2 ml of fresh medium in every well and harvest the solution cells/medium 
in a new falcon 
3. Centrifugation for 5 min at 1000 rpm 
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4. Aspirate the supernatant which also contains the trypsin. Add new medium in 
the cell pellet and seed the cells on a new (bigger) flask  
Note: After every trypsinization the passage number is increased (n+1) 
  
Β.3.2  Transfection of the cells with foreign DNA 
The term transfection denotes the introduction of foreign DNA into cell cultures. 
There are two types: the transient and the stable integration of foreign DNA. In 
transient integration the expression of the foreign DNA lasts for only a short period of 
time, while in the steady integration the foreign DNA is permanently integrated in the 
cell genome. Depending on the cell type different methods of transfection are used. 
Chemical: Lipofection, Calcium-Phosphate-Precipitation and Physical: 
electroporation, microinjection. 2-3 days before the transfection sufficient quantity of 
cells (80000/well) are seeded into wells containing cover slips. Analysis of the 
exogenous DNA expression is performed 2-3 days after infection. 
 
Β.3.6.1  Calcium-Phosphate transfection method 
Necessary Solutions:  2x HBS (pH=7,1)   280 mM NaCl 
       50 mM Hepes 
       1,5 mM Na2HPO4 
              2 M CaCl2  
All the solutions are filtrated to be sterilized and stored at -20 οC 
1. Medium Change (2 ml) before the transfection is advised 
2. Per Well of a 6 well plate. The following solutions are prepared in an 
eppendorf tube: 
i. Plasmid DNA, then add to 140 μl dH2O and 20 μl CaCl2
 by 
drops 
ii. Add as well by drops 160 μl 2x HBS (Note: not vortexing) 
iii. Incubate the mixture for 30 min at room temperature, while 
carefully stirring regularly   
iv. 300 μl of this mixture are dropped carefully on the cells 
3. Incubate the cells over night, 37 οC, 5% CO2 
4. The next day the cells are washed  2 times with PBS and then fresh medium 
is added to them 
5. 2-3 days after transfection cells are ready to be used for any other purposes 
 
B.3.6.2 MEF cells transfection 
  
MEF cells were transfected with: 3 μg pmT/mG, 3 μg pmT/cGi500, 2 μg pUC19 and 2 
μg pIC-Cre. 
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Β.3.7  Cell fixation and nuclei Hoechst33258 staining 
 
Necessary solutions: Immuno Fix:   Formaldehyde (3,7%)  in PBS     
                                                                 
1. Cells are washed  2 times with 3 ml PBS each time 
2. Add 2 ml of cold Immuno- Fix and incubate on ice for 10 min 
3. Aspirate Immuno-Fix and wash the cells 2 times with 3 ml PBS each time  
4. Stop the fixation with 2 ml PBS including 1% BSA and 1 μg/ml Hoechst 33258 
5. Lift up coverslips and wash them carefully with dΗ2O. Place them with the 
cells side down, on an object slide on which there is one drop of IMMU-
MOUNT (Thermo) 
6. The Object slides must be kept out of light until the cells are about to be 
observed under the microscope 
 
 
B.4 Microscopy 
The construct-sensor cGi500 (in the fixed cells) was observed in the YFP channel, as 
this is brighter, shows fewer background than the CFP channel, and bleaching is less 
severe at higher wave lengths. As the camera records intensities (= grayscale 
images), and no color information, one has to assign a certain color table to the 
image. The YFP channel could have been also color-coded in yellow, but for the 
overlay with red color-coded images (non Cre-recombined cells) and the Hoechst 
staining (nuclei), which is blue color-coded, green, is more convenient. To perform 
the pictures’ overlay we used the program ImageJ [Martin Thunemann]. 
 
Microscope: Zeiss Axiovert 200  
Light Source: Oligochrome (TILL Photonics)  
Camera: Qimaging Retiga 2000R  
Filter-sets: Nuclei: EX: 340/26 nm, DCLP: 410 nm, LP: 440 nm 
                  YFP: EX: 497/16 nm, DCLP: 516 nm, EM: 535/22 nm  
                   CY3: EX: 543/22 nm, DCLP: 565 nm, EM: 610/75 nm 
Software: Live Acquisition (TILL Photonics) 
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C.  Results 
Overall View of the Project Strategy 
Picture 13 
The above figure shows a schematic representation of the project strategy that was followed. 
(The figure has been drawn by Martin Thunemann) 
The parental targeting vector pR26mT/mG (obtained from: Liqun Luo, PMID 
17868096, Addgene plasmid 17787) [1] was initially digested with AscI/PacI 
producing two fragments: 7,2 kb and 9,8 kb. The 7,2 kb fragment was sub-cloned 
into the AscI/PacI digested pLinker3 producing a 9,8 kb plasmid, the pmT/mG. From 
the pmT/mG we excised the loxP-mG-pA fragment (1,2 kb) by digestion with 
EcoRI/HindIII. This fragment was sub-cloned into EcoRI/HindII digested pUC19 
producing thus the pUC-loxP-EGFP-pA plasmid (3,8 kb). From the pUC-loxP-EGFP-
pA plasmid the mG (EGFP) fragment (866 bp) was excised by Kpn2I/XhoI and 
replaced by a multiple coning site (40 bp) coding for the restriction enzyme sites: 
FseI, XmaI, AsiSI, MluI. This plasmid was named pUC-loxP-MCS-pA (3 kb).  
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Generation of a pR26-CAG-mT/cGi targeting vector (II)
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Picture 14 
The above figure shows a schematic representation of the project strategy that was followed. 
(The figure has been drawn by Martin Thunemann) 
The plasmid pUC-loxP-MCS-pA (3 kb) was then digested with HindIII/EcoRI and the 
loxP-MCS-pA fragment (369 bp) was sub-cloned back again to the HindIII/EcoRI 
digested pmT/mG, producing the pmT/MCS plasmid (9 kb). At that stage, we cloned 
in the MCS the cGi500 sensor (2264 bp) and the sr39tk (1181 bp) producing the 
pmT/cGi500 and the pmT/sr39tk plasmids respectively. The last step (which was 
accomplished by Barbara Birk) involved the sub-cloning of the AscI/PacI digested 
pmT/cGi500 (8,6 kb) and pmT/sr39tk (7,5 kb) back into the AscI/PacI digested 
parental targeting vector pR26mT/mG (9,8 kb) producing thus the targeting vectors 
pR26mT/cGi500 (18,5 kb) and the pR26mT/sr39tk (17,4 kb).  
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C.1 Initial materials: pRosa26mT/mG (0,8 μg/μl) and pLinker3 (1 μg/μl).  
The parental targeting vector pRosa26mT/mG (17 kb): 
 
 
C.2 Construction of the pmT/mG plasmid by sub-cloning of the pRosa26mT/mG 
(AscI, PacI) into the pLinker3 (AscI, PacI) 
 
Picture 15 
A schematic figure showing the first cloning step. The 7,2 kb fragment obtained from the 
parental targeting vector after digestion with AscI/PacI was sub-cloned into the AscI/PacI 
digested pLinker3, producing thus the plasmid pmT/mG ( pLinker3 plasmid card as well as all 
other plasmid cards can be found in the appendix II). 
 
The original plasmid pRosa26mT/mG was too big (17 kb) and therefore difficult to 
handle it. Additionally, cutting out the mG fragment by HindIII/EcoRI would destroy 
the targeting vector as these enzymes cut also in the homology arms. For this reason 
the initial step was to sub-clone the pRosa26mT/mG (insert) obtained after digestion 
with the restriction enzymes AscI/PacI, into one plasmid specifically constructed for 
this purpose, the pLinker3 (vector).  
20 μg from each plasmid is digested over night with the enzymes: AscI/PacI 
according to the provider’s instructions. The pR26mT/mG when digested with 
AscI/PacI, gives two fragments of 9,8 and 7,2 kb, while the pLinker3:  2,6 kb and 29 
bp. In the reaction of pR26mT/mG we add the enzyme EcoRV so that the bands can 
pR26mT
/mG 
Insert: 
7,2 kb 
 
pLinker3
Vector: 
2,6 kb 
pmT/mG 
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be better separated (the 9,8 kb band is cut into pieces)  in order then to isolate the 
7,2 kb band. The 2,6 kb band is needed from the pLinker3 . The vector has been 
incubated with CIP for 1 h. 
 
      
Picture 16  
The above picture shows an analytical gel electrophoresis. On the left: digested with 
PacI/AscI pLinker3 and on the right: digested pR26mT/mG with AscI/PacI and 
AscI/PacI/EcoRV (the arrows show the bands that need to be electro-eluted). 
The reactions were loaded on a preparative gel electrophoresis, from which the 
desired bands were isolated by electro-elution. After precipitation, an analytical gel 
electrophoresis was loaded in order to estimate the DNA concentrations and to 
calculate the vector/insert ratios for the ligation reactions. 
         M    V     I 
 
Picture 17 
Picture 17 shows an analytical gel electrophoresis after precipitation of the electro-eluates. 
1,5 μl out of 30 μl insert and 2 μl out of 40 μl vector have been loaded on the gel.  
 
-        +          -        +      +    M 
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Ligation Reactions 
The ligation reactions ratios were calculated according the above gel shown in 
picture 2. 
Incubation overnight at 10 οC 
Vector 0,1 μΙ 0,5 μΙ 1 μΙ 0,5 μΙ 0,5 μΙ 
Insert 6 μΙ 6 μΙ 6 μΙ 12 μΙ   
     
    M 
 
Picture 18 
Picture 18 shows the ligation reactions before Τ4-DNA-ligase inactivation and precipitation 
(samples were loaded as shown in the table above).  
 
 Vector 0,5 μΙ 0,1 μΙ 1 μΙ 0,5 μΙ 0,5 μΙ 
Insert 
 
6 μΙ 6 μΙ 6 μΙ 12 μΙ 
    
     M 
 
Picture 19 
Picture 19 shows the ligation reactions after Τ4-DNA- ligase inactivation and precipitation 
(samples were loaded as shown above).  
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The ligation reactions have been electroporated into bacteria, which were plated on 
agar plates + Amp. 8 unique clones were inoculated for mini-preps. 
 
Picture 20 
Picture 20 shows an analytical gel electrophoresis with DNA from mini preps digested with 
EcoRI. Digestion of the pmT/mG with EcoRI results to one 9,8 kb (linear) band. Clone number 
4 (in circle) was inoculated for a 500ml culture (maxi-prep).  
C.2.1 Maxi-prep Confirmation 
 
DNA obtained from maxi prep: concentration: 1 μg/μΙ, Volume: 370 μΙ 
     M   -   E  A  P   A+P 
 
Picture 21 
200 ng DNA from the maxi-prep were digested with AscI, PacI, EcoRI. The pmT/mG plasmid 
becomes linear (9,8 kb) by AscI, PacI, EcoRI. While by AscI/PacI results in two 2,8 and 7,2 kb 
bands. 
 
C.3 Construction of the pUC-loxP-EGFP-pA plasmid 
The next step was to excise the mG (loxP-EGFP-pA) from pmT/mG by HindIII/EcoRI 
and to sub-clone it into pUC19.  
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Picture 22 
The second step was to excise the mG [loxP-EGFP-pA (1,2 kb)] from pmT/mG by 
HindIII/EcoRI and to sub-clone it into the HindIII/EcoRI digested pUC19 (2,6 kb). The plasmid 
that was generated is the pUC-loxP-EGFP-pA (3,8 kb). 
 
Μ   -  Ε  Η  Ε+Η Α+Ρ 
                        1,2 kb fragment 
Picture 23 
Τhe picture above shows the digestion of the pmT/mG by EcoRI, HindIII, PacI, AscI. 
Digestion with EcoRI/HindIII gives two bands: 1,2 and 8,6 kb. 
 
20 μg of pmT/mG and pUC19 were digested over night with EcoRI/HindIII.  
 
 
 
 
pmT/mG 
 
 
loxP-EGFP-
pA (insert) 
pUC19: 
vector 
pUC-loxP-
EGFP-pA 
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 M   -  +    -  + 
 
Picture 24 
The picture above shows: On the left: digestion of pUC19 with EcoRI/HindIII (2,6 kb and 51 
bp) and on the right: digestion of  pmT/mG with the same enzymes (1,2 kb and 8,6 kb). The 
arrow indicates the 1,2 kb band that has to be electro-eluted. 
The reactions were loaded on a preparative gel electrophoresis and the bands: 2,6 
and 1,2 kb were electro-eluted. 
 M  V  I           M  V  I 
 
Picture 25 
The Picture 25 shows an analytical gel electrophoresis to determine DNA concentration of the 
electro-eluates. The end volume of the samples was in 30 μl Η2Ο each. Out of this amount 
were loaded on the gel: On the left part: 1 μΙ pUC19 and 1 μΙ mG. On the right part: 2 μΙ 
pUC19 and 2 μΙ mG.  
According to the above results we calculated the ligation reactions:  
vector  0,8 μΙ 0,4 μΙ 2 μΙ 0,8 μΙ   2 μΙ 
insert  8 μΙ 6 μΙ 5 μΙ   5 μΙ   
 
The ligation reactions: 0,8:8  0,8  2:5  and 2 were electroporated into bacteria and 
plated on plates.  
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 M  -  E E+H -  E E+H -  E E+H  
  
Picture 26 
This Picture shows an analytical gel electrophoresis from 3 mini-preps digested with EcoRI 
and EcoRI/HindIII. Digestion with EcoRI gives a linearized molecule of 3,8kb, while digestion 
with EcoRI/HindIII two bands of 1,2 and 2,6 kb respectively. The clone number 3(indicated by 
the circle and the arrow) was inoculated for maxi-prep. 
 
C.3.1 Maxi-prep Confirmation  
 Concentration: 1 μg/μΙ, Volume: 935 μΙ 
 M   -  E  H  E+H 
 
Picture 27 
The picture above (C.27) shows an analytical gel where samples from the maxi-prep have 
been loaded. Digestion with: EcoRI, HindIII and EcoRI/HindIII.  
 
C.4 Construction of the pUC-loxP-MCS-pA plasmid 
To construct the pUC-loxP-MCS-pA plasmid, the mG fragment (872 bp) was excised 
out of the pUC-loxP-EGFP-pA plasmid, and it was replaced by a MCS.  
Maxi-prep 
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Picture 28 
The figure 28 shows the generation of the pUC-loxP-MCS-pA plasmid (3 kb). The 3 kb 
plasmid remaining after digestion of pUC-loxP-EGFP-pA with Kpn2I/XhoI was used as a 
vector and the MCS oligonucleotides as an insert. 
20 μg of pUC-loxP-EGFP-pA were digested overnight with XhoI according to the 
provider’s instructions. The next day the reaction was precipitated and digested then 
with the Kpn2I overnight in another reaction buffer.  
    Μ  Κ+Χ 
     
Picture 29 
3 kb (V) 
872 kb 
 
pUC-loxP-EGFP-pA (3836 bp) 
 
 
 
 
EGFP (872 bp) excised by 
Kpn2I/XhoI and replaced by a 
Multiple Cloning Site 
 
 
pUC-loxP-MCS-pA (3 kb) 
 
MCS: FseI, XmaI, AsiSI, MluI 
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The Picture 29 shows an analytical gel on which it has been loaded 1 μg DNA out of 20 μg. 
The 3kb band needs to be electro-eluted. 
 
Μ  -   Ε+Η Κ+Η Ε.Ε 
 
Picture 30 
Picture 30 shows an analytical gel on which it has been loaded: pUC-loxP-EGFP-pA (100 ng) 
digestion with EcoRI/HindIII, Kpn2I/XhoI as well as 1 μΙ on the left and 0,5 μΙ on the right out 
of 30 μΙ of the electro-eluates.   
According to the above gel, the ligation reactions are calculated: 
  pUC-loxP-MCS-pA   
    vector (3kb) 2 μΙ 2 μΙ 2 μΙ 
insert (oligos 
Β.1.4.2  ) 
2 μΙ 0,2 μΙ   
    
Μ  R 2:2 2:0,2 
 
Picture 31 
The picture above shows the ligation reactions after the Τ4-DNA-ligase inactivation and the 
DNA precipitation.  
The ligation reactions were electroporated into bacteria and plated on agar plates.10 
and 100 μΙ of the electroporation bacteria were plated. 
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        2:0,2  10μΙ            2:2   100μΙ          
 Μ -1+1 -2+2 -3+3    -1+1-2+2 -3+3   
 
Picture 32 
The picture C.32 shows 6 mini-preps from the pUC-loxP-MCS-pA that have been digested 
with MluΙ (linearized molecule 3 kb). The clone number 1 (2:2, 100 μΙ) shown in circle was 
inoculated for maxi prep. 
 
C.4.1 Maxi prep confirmation 
Concentration: 1,07 μg/μl , Volume: 190 μΙ  
 
   Μ -   Η  Ε 
   
Picture 33 
Picture number 33 shows the pUC-loxP-MCS-pA digestion with EcoRI, HindIII. The molecule 
is a linearized 3 kb DNA. 
C.5 Construction of the pLinker5 
    
Picture 34 
pLinker5 2,6 kb 
Vector: pUC19 digested with 
EcoRI/HindIII 
Insert: Oligonucleotides for 
pLinker5 
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The Picture 34 shows the schematic representation of the pLinker5 (2687 bp). To generate it, 
pUC19 was digested with EcoRI/HindIII and used as a vector for the oligonucleotides (insert). 
To sub-clone and multiply the CMV-cGi500 (sensor) and the thymidine kinase CMV-
sr39tk it was necessary to construct a vector, based on the pUC19 that will have a 
cloning site designed so that it will be able to introduce these plasmids and allow an 
easy handling of them afterwards. The pUC19 was digested with EcoRI/HindIII and 
used as a vector in a ligation reaction and as insert the oligonucleotides (B.1.4.2) that 
coded for the desired restriction sites. The ligation reactions are: 
  pLinker5     
    vector (2,6 kb) 2 μΙ 2 μΙ 2 μΙ 
insert (oligos) 2 μΙ 0,2 μΙ   
 
     Μ  R  2:2  2:0,2  
     
Picture 35 
Picture 35 shows the ligation reactions for pLinker5 construction, after the Τ4-DNA-ligase 
inactivation and precipitation.  
The ligation reactions were electroporated into bacteria and plated on agar plates: 10 
and 100 μΙ.  
 Μ -1+1 -2+2 -3+3    -1+1-2+2 -3+3   
 
Picture 36 
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Picture 36 shows 6 mini-preps digested with NcoI (linearized molecule 2,6 kb) . On the left 
part you can see samples from the reaction 2:2, 10 μΙ, while on the right 2:0,2, 10 μΙ. Clone 
number 2 (2:2, 10 μΙ) was inoculated in a maxi-prep.     
 
C.5.1 Maxi-prep Confirmation 
Concentration: 1,1 μg/μl, Volume: 190 μΙ 
 
Μ  -   Β  Ν  Η 
 
Picture 37 
An analytical gel to confirm the maxi-prep. It has been loaded on it:  75 ng pLinker5 digested 
with BamHI, NcoI, HindIII (linearized DNA 2,67 kb).  
 
C.6 Subcloning of the CMV-cGi500 into pLinker5 (pL5-cGi500) 
 
Picture 38 
Picture 38 shows the generation of the pL5-cGi500 (4,9 kb).  
Taken from the stock (1 μg/μl) CMV-cGi500 (7767 bp). Digestion of 200 ng DNA with 
the enzymes NcoI/EcoRI.  The 2243 bp band is the required sensor band. Below you 
can see the bands resulting when digesting the CMV-cGi500 sensor with 
NcoI/EcoRI. 
CMV-cGi500 
digested with 
NcoI/EcoRI. The 
2243 bp band was 
used as an insert 
and the pL5 
digested with the 
same enzymes as 
a vector. 
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CMV-cGi500, NcoI/EcoRI
4457 bp
2243 bp
505 bp
471 bp
91 bp  
  
Μ   -  + 
 
Picture 39 
100 ng DNA that has been digested with NcoI/EcoRI, was loaded on the gel. The 2243 bp 
band (indicated by the arrow) is required for the electro-elution.  
C.6.1 Preparative Digestions  
15 μg of pLinker5 and CMV-cGi500 were incubated overnight with EcoRI/NcoI. About 
450 ng DNA is shown in the picture bellow. The pLinker5 was also incubated with 
CIΡ.   
 M 
 
Picture 40 
Picture 40 shows the bands resulting from the digestion of pLinker5 and CMV-cGi500 with 
EcoRI/NcoI. On the right: CMV-cGi500 (shown by the arrow), on the left: pLinker 5. 
 
 
Sensor band-cGi500 -
(2243 bp)->Insert 
Required for the 
electro-elution 
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  Μ 
          
Picture 41 
The above picture shows an analytical gel on which it has been loaded:  2 μΙ out of 20 μΙ of 
the electro-eluates .On the left side: pLniker5, on the right side: cGi500. 
Ligation Reactions:  
EcoRI/NcoI
pL5 3 3
cGi500 8   
  Μ  R pL5:cGi500                      Μ    R pL5:cGi500 
                                             
Picture 42                                           Picture 43 
The pictures above show analytical gels on which have been loaded the ligation reactions 
before (left) and after (right) the Τ4-DNA-ligase inactivation and precipitation.  
  Μ -  +   -   +  -  +  -   +     -  +                                           Μ   -   + 
                                          Picture   44                                     Picture 45                                                                                      
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Picture 44 (left) is shows the mini-preps of the pL5cGi500, 3:8, 10 μl, digestion with: EcoRI 
(linearized: 4912 bp). Picture 45 (on the right): Clone 3 has also been digested with 
EcoRI/HindIII (1098, 3814 bp). Clone number 3 was inoculated in maxi-prep (shown in circle). 
C.6.2 Maxi-prep Confirmation 
Concentration: 1034 ng/μl, Volume: 320 μΙ  
  Μ   -  F  N+E F+E  
 
Picture 46 
In the picture above it is shown 125 ng DNA of pL5cGi500 that has been digested with: FseI, 
NcoI, EcoRI. (FseI: 4,9 kb, NcoI/EcoRI: 2,2 kb 2,7 kb, FseI/EcoRI: 2,2 kb 2,7 kb) 
  
C.7 Subcloning of the CMV-sr39tk into pLinker5 (pL5-sr39tk) 
 
Picture 47 
Generation of the pL5-sr39tk (3,8 kb). 
Stock (1 μg/μl) CMV-sr39tk (6556 bp). Digestion of 200 ng DNA with the enzymes: 
NcoI/BamHI. The 1154 bp band is the required sr39tk. 
CMV-sr39tk, NcoI/BamHI
3342 bp 
1154 bp
1032 bp
735 bp
293 bp  
 
CMV-sr39tk: 
digested 
with 
NcoI/BamHI 
The 1154 bp 
band was 
used as an 
insert and 
the pL5 
digested 
with the 
same 
enzymes as 
a vector. 
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 M  -   sr39tk  
 
Picture 48  
Picture 48 shows 100 ng DNA digested with NcoI/BamHI that were loaded on the gel. The 1154 
bp band is going to be electro-eluted (arrow).  
C.7.1 Preparative Digestions  
15 μg of pLinker5 and CMV-sr39tk were digested overnight with BamHI/NcoI. The 
pLinker5 was also incubated with CIΡ.  
 Μ 
 
Picture 49 
The picture 49 shows an analytical gel on which 450 ng DNA has been loaded. On the right: 
CMV-sr39tk (indication by the arrow), on the left: pLinker5.  
 Μ  pL5 tk 
                          
Picture 50 
Electro-
eluates: 
sr39tk (1154 
bp)->insert 
vector: pL5 
(2,6 kb) 
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The picture 50 shows an analytical gel on which it has been loaded 2 μΙ out of the 20 μΙ of the 
electro-eluates. On the left: pLniker5, on the right: sr39tk. 
 
Ligation Reactions: 
BamHI/NcoI
pL5 3 3
sr39tk 12  
 
  M  R  pL5:tk                                                           M   R  pL5:tk 
                                                
Picture 51                                                                          Picture 52             
The pictures above show gels of the ligation reactions. On the left before and on the right 
after Τ4-DNA-ligase inactivation and precipitation.  
 Μ   - +  -  +   -    +  -   +   -  +  
 
Picture 53  
Above are shown the mini-preps of pL5sr39tk, 3:12, 10 μl, digestion with: EcoRI (linearized 
molecule: 3829 bp). Clone 1 (circle) has been inoculated in a maxi-prep. 
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C.7.2 Maxi-prep confirmation  
  Μ  -Ν+Β Ν+Μ F+B                Maxi-prep Concentration: 1,1 μg/μΙ  Volume: 920 μΙ 
                                                      
Picture 54 
About 125 ng DNA of pL5sr39tk that has been digested with: FseI, NcoI, BamHI, MluI is 
shown above. (FseI/BamHI: 2,6 kb 1,2 kb, NcoI/MluI:  2,7 kb, 1,1 kb 0,027 kb, NcoI/BamHI: 
2,6 kb 1,1 kb) 
C.8 Construction of the pmT/MCS plasmid  
 
 
Picture 55 
Picture 55 shows the generation of the pmT/MCS (9 kb). The loxP-MCS-pA (369 bp) fragment 
from the pUC-loxP-MCS-pA (3 kb) was used as an insert. The HindIII/EcoRI digested 
pmT/mG (8683 bp) fragment was used as a vector.  
 
pUC-loxP-MCS-pA     
(3 kb) 
 
loxP-MCS-pA : (369 
bp) was excised with 
HindIII/EcoRI -> insert 
 
 
pmT/mG digested with 
HindIII/EcoRI->vector 
pmT/MCS ( 9 kb) 
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20 μg of pUC-loxP-MCS-pA and pmT/mG were digested with EcoRI/HindIII 
overnight. 
 
Picture 56 
The Picture 56 presents an analytical gel electrophoresis (about 1 μg of pUC-loxP-MCS-pA 
has been loaded). The 369 bp band is required for the electro-elution (shown by the arrow).  
  Μ pmT MCS 
 
Picture 57 
4 μΙ of pmT (8683 bp->vector) and 4 μΙ of MCS (369 bp->insert) out of the 40 μΙ of electro-
eluates.  
 
Ligation Reactions are being calculated according to the above gel:  
EcoRI/HindIII       R 
“pmT” (vector) 3μΙ 3μΙ  
MCS (insert) 6μΙ   
 
 
 
 
 
 
 
369 bp band      
->Insert 
 
 
Vector 
 
 
Insert 
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  Μ  R  pmT/MCS                                             Μ  R  pmT/MCS 
                                                   
Picture 58                                                                Picture 59                          
Ligation Reactions (pmT/MCS 3:6) before (on the left) and after (on the right) Τ4-DNA-ligase 
inactivation and precipitation.  
pmT/MCS, 3:6, 10 μl                                                   pmT/MCS, 3:6, 100 μl 
 M   -  +    -   +   -   +                                                     M   -  +   -   +  -   + 
                                                       
Picture 60                                                                            Picture 61 
Mini-preps of pmT/MCS digested with EcoRI (linearized molecule: 9884 bp). 
  Μ  -1 +1  -1 +1 -2 +2 
                  369 bp 
Picture 62 
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Picture 62: Clones: 1 (pmTMCS, 3:6, 100 μl) and 1,2 (pmTMCS, 3:6, 10 μl) were incubated 
with EcoRI/HindIII. The bands (8683 bp, 369 bp) are shown on picture 62. Clone 1 (pmTMCS, 
3:6, 100 μl) was cultured in a maxi-prep (indicated by the circle).  
C.8.1 Maxi-prep confirmation 
Concentration: 1080 ng/μΙ, Volume: 210 μΙ 
  Μ  - F  A+P M 
 
Picture 63 
125 ng of pmT/MCS digested with: FseI, MluI, PacI, AscI (FseI, MluI: linearized, 9 kb, 
Asc/PacI: 2,6 and 6,4 kb ). 
 
C.9 Subcloning of the pL5-cGi500 into pmT/MCS (pmT/cGi500) 
  
 
Picture 64 
The picture 64 shows the construction of pmT/cGi500 (11297 bp). The plasmid pL5-cGi500 
(4,9 kb) was digested with FseI/AsiSI and the resulting fragment (2264 bp)->insert, was 
sub-cloned into pmT/MCS digested with the same enzymes (9033 bp)->vector. 
pL5-cGi500 
digested 
with 
FseI/AsiSI 
(2264 bp)-> 
insert 
 
 
pmT/cGi500 
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20 μg of pL5-cGi500 and pmT/MCS were incubated overnight with FseI/AsiSI. In the 
reaction of the pL5-cGi500 the enzyme AseI is also added in order the excision of the 
2264 bp band to become easier.  
 Μ cGi500, pmTMCS 
                                       
pmT/MCS cGi500 cGi500
FseI/AsiSI FseI/AsiSI/AseI AsiSI/AseI
9033 bp 2264 bp 3485 bp
19 bp 1235 bp 1235 bp
1221 bp 133 bp
133 bp 59 bp
59 bp  
Picture 65  
The Picture 65 shows about 200 ng out of the preparative reactions. It can be clearly seen 
that the FseI doesn’t cut properly, because a 3,5 kb band appears  (cut only with AseI, 
AsiSI).The desired band is indicated by the arrow.  
   
Μ pmTMCS,cGi500 
  
Picture 66 
Picture 66 shows an analytical gel after the electro-elution of the desired bands, in order to 
determine the DNA concentration to calculate the ligation reaction ratios.  
Ligation Reactions 
FseI/AsiSI     
pmT/MCS 1 μΙ 1 μΙ 
cGi500 8 μΙ    
 
 
 
 
Sensor 
band 
(2264 bp   
->insert 
 
Vector (9 kb) 
Insert (2,2 kb) 
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  Μ 1:8 R  
  
Picture 67 
Shows the ligation reactions after Τ4-DNA-ligase inactivation and precipitation. The vector 
has not been incubated with CIP. 
M   -1  +1 -2 +2  -3 +3 -4  +4  -5 +5 -6 +6  -7 +7 -8 +8 
 
Picture 68 
8 mini-preps of the pmT/cGi500 digested with HindIII (1,2 kb and 10 kb) are shown above. 
Clone number 6 (shown in circle) is the right one. The others could be vector religation as this 
was not incubated with CIP (aprox.9 kb) 
  Μ   -  Η  Α+Ρ+Α 
  
Picture 69 
The Picture 69 shows the 6
th
 clone from the above mini-preps which has been additionally 
digested with HindIII (1,2 kb 10 kb), AsiSI/AscI/PacI (6,5 kb 2,1 kb 2,6 kb). This Clone 6 was 
cultured in a maxi-prep.  
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C.10 Subcloning of the pL5-sr39tk into pmT/MCS (pmT/sr39tk) 
 
Picture 70 
The picture 70 presents the construction of the pmT/sr39tk (10,2 kb). To generate the 
pmT/sr39tk plasmid, the pL5-sr39tk plasmid was digested with FseI/AsiSI (insert) and sub-
cloned into FseI/AsiSI digested pmT/MCS (vector, 9033 bp)  
 
20 μg of pL5-sr39tk and pmT/MCS were digested overnight with FseI/AsiSI.   
 M       I   V 
                                     
pmT/MCS (V) sr39tk (I)
FseI/AsiSI FseI/AsiSI
9033 bp 2648bp
19 bp 1181 bp
 
Picture 71 
200 ng of pmT/MCS and pL5-sr39tk out of the preparative reactions were loaded on the gel. 
The 9033 bp band of the pmT/MCS and the 1181 bp band of the sr39tk need to be electro-
eluted. 
   
 
 
 
 
pL5-sr39tk      
( 3,8 kb) 
digested with 
FseI/AsiSI -> 
insert (1181 
bp) 
 
pmT/sr39tk  
 
Vector 
 
Insert 
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   Μ  V   I  
 
Picture 72 
3 μΙ out of 60 μΙ of the electro-eluate has been loaded on the gel shown above in order to 
estimate the DNA concentration and the ligation reactions 
Ligation Reactions 
FseI/AsiSI     R  
pmT/MCS(V) 2 μΙ 2 μΙ 2 μΙ 
sr39tk(Ι) 10 μΙ  15 μl   
   
  Μ   R 2:10 2:15 
 
Picture 73 
The ligation reactions after Τ4-DNA-ligase inactivation and precipitation are shown above.  
   Μ -1 +1 -2 +2 -3+3 -4 +4 -5 +5 -6 +6-7 +7-8 +8 
Picture 74  
Vector 
 
Insert 
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 Μ  -9 +9                                                     -16+16 
 
Picture 75 
  Μ-17+17                 -20+20 
 
Picture 76 
The pictures above 74, 75, and 76 show the mini-preps (1-20) of the pmT/sr39tk digested with 
HindIII (8991 bp and 1223 bp). Clones: 4, 7, 13, 14 and 16 are vector religation. Clone 6 
(shown in circle) was inoculated in a maxi-prep. 
C.10.1 Maxi-prep confirmation  
  Μ   - P/F A/F A/P H/A H/P                       Concentration: 1437 ng/μl,  Volume: 620 μΙ 
     
FseI/AscI FseI/PacI HindIII/AscI HindIII/PacI PacI/AscI
6902bp 5960bp 6820bp 4819bp 7566bp
3312bp 4254bp 2171bp 4172bp 2648bp
1223bp 1223bp
pmT/sr39tk
 
Picture 77 
200ng of pmT/sr39tk were digested with the enzymes: AscI/FseI, PacI/FseI, HindIII/PacI, 
HindIII/AscI, PacI/AscI. About 100 ng of the analytical reactions above are shown in the gel. 
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C.11 Construction of the pR26mT/MCS (targeting vector) 
 
 Picture 78 
 The above picture shows the generation of the targeting vector pR26mT/MCS (16.2 kb) 
which can be used in order to sub-clone any gene of interest into the MCS. The pmT/MCS 
was digested with AscI/PacI and the 6,4 kb fragment (insert) was cloned back again to the 
parental targeting vector which was digested with the same enzymes (vector: 9,8 kb). 
 
20μg of pR26mT/mG and pmT/MCS were incubated overnight with PacI/AscI.  
  Μ   Ι  V 
                          
pmT/MCS(I) Rosa26mT/mG(V)
6404 bp 9862 bp
2648 bp 7236 bp
AscI/PacI
 
Picture 79  
100 ng of the preparative reactions are shown in the picture 79 (the red arrow indicates the 
vector- 9,8 kb while the green one indicates the insert 6,4 kb). 
 
 
 
 
  
 
pmT/MCS 
cut out with 
PacI/AscI  
->insert (6,4 
kb) 
 
pR26mT/MCS 
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 Μ            V 
                                             
AscI/PacI/XbaI
Rosa26mT/mG
9862 bp
3750 bp
1643 bp
1477 bp
317 bp
49 bp  
Picture 80 
100 ng of the pR26mT/mG. In the reaction the enzyme XbaI was also added. The 9,8 kb band 
needs to be electro-eluted (also incubated with CIP).  
 Μ V        I 
  
Picture 81 
Analytical gel to determine the DNA concentration for the ligation reactions.1 μl DNA out of 
the 50 μΙ of the electro-eluates (vector, insert). 
Ligation Reactions 
PacI/AscI
pR26mT/mG (V) 4μl 4μl 4μΙ
pmT/MCS (I) 6μΙ 8μΙ  
 Μ  4:6 R                        Μ 4:8 R 
 Picture 82          Picture 83    
vector 
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 Pictures 82, 83: Ligation Reactions after precipitation and T4-DNA-ligase inactivation.   
  Μ     -   +    -   +    -   +      -   +     -   + 
  
Picture 84 
The Picture 84 shows the mini-preps of the 4:6 ligation reaction. Digestion with NheI/FseI 
(12399, 3509, 358 bp). The proper clone does not exist. It is rather only the religation of the 
insert (pmT/MCS) 9 kb. 
  Μ     -   +    -   +     -   +    -   +     -   + 
 
Picture 85 
The Picture 85 shows the mini-preps of the 4:6 ligation reaction. Digestion with EcoRI (10088, 
6178 bp). There is not a proper clone here either.  
  Μ    -   +    -   +  -   +   -   +   -    +   -   +   -   +   -   + 
 
Picture 86 
Mini-preps, 4:8, 300 μΙ, EcoRI: 10088, 6178  bp.  
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  Μ     -   +   -   +  -   +    -   +   -   +   -   +    -   +   -   + 
  
Picture 87 
Mini-preps, 4:8, 100 μΙ, EcoRI: 10088, 6178 bp. Unknown region of DNA. 
 
None of the above mini-preps shown in the pictures 84-87 had the proper bacterial 
clone. Its rather insert religation (9 kb) or/and unknown DNA! 
 
C.12 Construction of the pR26mT/cGi500 (targeting vector) 
 
Picture 88 
Construction of the targeting vector pR26mT/cGi500 (18,5 kb). To generate the 
pR26mT/cGi500, the pmT/cGi500 was digested with AscI/PacI (insert: 8,6 kb) and was sub-
cloned into AscI/PacI digested pR26mT/mG (vector: 9,8 kb). 
 
 
pmT/cGi50
0 digested 
with 
AscI/PacI-> 
(8,6 kb 
insert) 
 
pR26mT/c
Gi500  
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16μg of pR26mT/mG and 20 μg of pmT/cGi500 were digested overnight with 
PacI/AscI (+XbaI). 
 pR26mTmG    pmTcGi500 
(PacI/AscI/XbaI)  (PacI/AscI) 
Μ   -   +   -  + 
                                              
AscI/PacI
pmTcGi500
8649 bp
2648 bp       
Picture 89 
200 ng out of the preparative reactions were loaded on this gel. From the insert (pmT/cGi500) 
the 8,6 kb band is needed while from the vector (pR26mT/mG) the 9,8 kb band (vector, insert 
are indicated by arrows). 
 
The ligation ratios are calculated according the nanodrop measurements. 
PacI/AscI
pR26mT/mG (V) 1μl 3μl 1μΙ 3μΙ
pmT/cGi500 (I) 6μΙ 6μΙ  
 
R1 1:6 R3 3:6 M 
 
Picture 90 
Ligation reactions after T4-DNA-ligase inactivation and precipitation.  
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Μ   -  +  -  +  -  +   -  +  -  +  -  +  -  +   -  +    Μ   -  +  -  +  -  +  -  +  -  +  -  +  -  +  -  + 
  
Pictures 91, 92 
The pictures above show the mini-preps of the 1:6, 3:6 ligation reactions (pR26mT/cGi500) 
(digested with XbaI: 11554, 5149, 1477, 317 bp). A right clone is not found! The resulting 
DNA is of unknown origin (pic.91) and some insert religation (pic. 92, 1-5 samples)! 
 
 C.13 Cell Culture Results 
MEF cells have been transfected with the plasmids bellow:  
1. pmT/mG + pUC19 
2. pmT/mG + pIC-Cre 
3. pmT/cGi500 + pUC19 
4. pmT/cGi500 + pIC-Cre 
 
Cells were fixed 2 days after transfection and observed under the microscope. In the 
1st case the cells should exhibit red fluorescence as they are co-transfected with 
pUC19. In the 2nd case pIC-Cre is co-transfected and excises the floxed td Tomato 
(mT) so that the cells show green fluorescence due to the mG fluorescent protein. In 
fact Cre recombinase needs some time in order to recombine all successfully 
transfected cells. This is why 2 days after transfection we observe some red 
fluorescence in the red channel along with the green fluorescence. But the red 
background should be much less compared to the 1st case (co transfection with 
pUC19). In the 3rd case the cells should also express the red fluorescent protein. In 
the 4th case the td Tomato (mT) is excised by the Cre recombinase just like in case 2. 
Under the microscope we observe the cGi500 sensor in fixed cells, in the YFP 
channel as no cGMP is bound on it. The microscope records only grey scale images 
(intensities) and no color. The image then is color-coded green, as this color enables 
better overlays with the blue nuclei pictures and the pictures from the red channel. 
The results of the microscopy are just as expected, revealing the perfect function of 
the constructs. 
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C.11.1 Transfection with pmT/mG + pUC19 
  
  
Picture 93 
Picture 93 shows the fixed MEF cells transfected with the plasmid pmT/mG and the pUC19. 
R,G show the cells in the red and green channel respectively while B shows the cells nuclei. 
Merge is the overlay of the three pictures.   
 
 
 
 
 
 
 
 
 
 
 
 
 
G
 R  
R 
Merge B 
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Transfection with pmT/mG + pUC19  
     
       
Picture 94  
Picture 94 shows the fixed MEF cells transfected with the plasmid pmT/mG and the pUC19. 
R,G show the cells in the red and green channel respectively while B shows the cells nuclei. 
Merge is the overlay of the three pictures.    
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C.11.2 Transfection with pmT/mG + pIC-Cre 
  
  
Picture 95 
Picture 95 shows the fixed MEF cells transfected with the plasmid pmT/mG and the pIC-Cre. 
R,G show the cells in the red and green channel respectively while B shows the cells nuclei. 
Merge is the overlay of the three pictures.   
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Transfection with pmT/mG + pIC-Cre  
  
        
Picture 96 
Picture 96 shows the fixed MEF cells transfected with the plasmid pmT/mG and the pIC-Cre. 
R,G show the cells in the red and green channel respectively while B shows the cells nuclei. 
Merge is the overlay of the three pictures.   
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C.11.3 Transfection with pmT/cGi500 + pUC19 
  
  
Picture 97 
Picture 97 shows the fixed MEF cells transfected with the plasmid pmT/cGi500 and the 
pUC19. R,G show the cells in the red and green channel respectively while B shows the cells 
nuclei. Merge is the overlay of the three pictures.   
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Transfection with pmT/cGi500 + pUC19 
  
   
Picture 98 
Picture 98 shows the fixed MEF cells transfected with the plasmid pmT/cGi500 and the 
pUC19. R,G show the cells in the red and green channel respectively while B shows the cells 
nuclei. Merge is the overlay of the three pictures.    
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C.11.4 Transfection with pmT/cGi500 + pIC-Cre 
  
  
Picture 99 
Picture 99 shows the fixed MEF cells transfected with the plasmid pmT/cGi500 and the pIC-
Cre. R,G show the cells in the red and green channel respectively while B shows the cells 
nuclei. Merge is the overlay of the three pictures 
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Transfection with pmT/cGi500 + pIC-Cre 
  
  
Picture 100 
Picture 100 shows the fixed MEF cells transfected with the plasmid pmT/cGi500 and the pIC-
Cre. R,G show the cells in the red and green channel respectively while B shows the cells 
nuclei. Merge is the overlay of the three pictures 
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D.  Discussion 
Using site specific recombination techniques it is now able to produce transgenic 
animal models for a variety of human diseases. The laboratory mouse is now one of 
the most popular animal-models. It's a mammal, small, breeds fast, and can be easily 
and relatively economically kept in the laboratory. The site-specific recombination 
system, Cre / lox, is now widely used to generate knockout and knock-in transgenic 
mice. It involves the construction of a «floxed» mouse which is a mouse that carries 
two loxP sites surrounding an exon that we want to silence. The introduction of two 
loxP sites is done by homologous recombination in ES cells, which are then injected 
into blastocysts and those in foster mothers for gestation. Then the above mouse is 
crossed with another one which expresses a tissue specific Cre recombinase. The 
tissue-specificity of the Cre can be easily driven by a tissue specific promoter. In the 
recombined offsprings of the above crossing, the «floxed» exon will be excised in all 
the tissues where the Cre is expressed. Moreover, it is possible to control the time 
onset of the Cre expression; using CreErT2 recombinases (see Introduction). The 
Cre/lox system can be also used to create chromosomal rearrangements. Many 
human cancers, which are known to be caused by chromosomal translocations, have 
now been modeled in mice through this system. 
Apart from cancer, heart diseases are also a large group of diseases that stimulate 
the biomedical community’s research interest. Today it is yet known that the drugs 
used in angina pectoris, pulmonary hypertension or erectile dysfunction, in anti-
thrombosis and atherosclerosis treatment are based on signaling through cyclic 
GMP. Exploring the ways in which cGMP is involved in these (patho-) physiological 
functions will allow apart from understanding these processes, to design more 
effective and perhaps with less side effects, medications and therapies. 
On the other hand, of great research interest is the cell tracking in order to monitor 
cell proliferation, migration and cell death in conditions of disease and health. To 
achieve this, is required a non-invasive cell marker and a tracking technique that 
does not harm the animal or the cell. Cell labeling may be done for instance by 
accumulation of a radioactive substance, the 9 - (4-18F-fluoro-3-[hydroxymethyl] 
butyl) guanine (18F-FHBG) and by detecting it by Positron Emission Tomography 
PET. More specifically using the targeting vector Rosa26mT/sr39tk the thymidine 
kinase is activated in cells expressing the Cre. In this way the radioactive product is 
phosphorylated and cannot exit the cells, where it accumulates. At this point it is 
possible to detect these cells with PET [15, 16].   
In this project, using a well working double fluorescent reporter plasmid (tdTomato 
before Cre recombination and GFP after Cre recombination) we tried to construct a 
targeting vector into the Rosa26 locus, that will have a Multiple Cloning Site for 
unique restriction enzymes in the entire targeting vector. The genetic locus Rosa26 is 
widely used to generate knock in transgenic mice because it has a significant 
advantage. First it ensures that the transgene expression is ubiquitous, and the 
construct will not fall into heterochromatin. Then the transgenic mice are viable and 
fertile, with no phenotypical changes compared to wild type ones. Finally, the original 
Rosa26 was placed in the 1st intron of the Rosa26 gene, so that the CAG promoter, 
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which comprises the cytoskeleton β-actin promoter and the CMV enhancer, will give 
high expression levels in the transgene compared to endogenous Rosa26 promoter. 
In the MCS (multiple cloning site) coding for recognition sites for the enzymes: FseI, 
XmaI, AsiSI, MluI we sub-cloned the cGMP sensor, cGi-500 and the sr39tk, a 
thymidine kinase variant of herpes simplex virus. The sensor cGi-500 consists of a 
cGMP binding domain surrounded by a CFP and a YFP. When the cGMP binds to 
the sensor the conformation changes (linear) and the two fluorescent proteins are 
then away from each other so that energy transfer from the CFP to the YFP cannot 
happen. In that case it is possible to detect the CFP color of  the sensor. In absence 
of cGMP though, the two fluorescent proteins are close enough for FRET to occur. 
Then it is possible to detect the YFP color. The usefulness of such a system is huge 
if we consider that it is possible to monitor cGMP levels in living cells and in fact in 
real time. With these sensors it is now possible to monitor, in living cells, the 
quantitative variances in cGMP concentration after administration of different drugs.   
Additionally, MEF cells transfection with the above constructs showed that it works 
very well in living cells. The cells showed red fluorescence when co-transfected with 
pUC19, and green fluorescence when co-transfected with Cre recombinase. The fact 
proves that the open reading frame has not be affected (shifted) after the whole 
construction process and that the cells are able to produce functional fluorescent 
protein. This was also proved by sequencing, which showed that the constructed 
plasmids are as expected from the Vector NTI ™ software.  
Finally, the targeting vectors pR26mT/cGi500 and pR26mT/sr39tk were finished by 
Barbara Birk with constructs and fragments that I isolated. They can now be used to 
generate genetically modified ES cells and furthermore transgenic mice.    
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Appendix 
Ι. Project Strategy 
Generation of a pR26-CAG-mT/cGi targeting vector (I)
5' HA CAG mT mG
p
A
p
A
PGK-Neo
p
A
3' HA Backbone
PacI AscI
CAG mT mG
p
A
p
A
PGK-Neo
p
A
PacI AscI
Backbone
NgoMIV HindIII EcoRI
HindIII EcoRI
mG
p
A
HindIII EcoRI
Backbone
EcoRI
HindIII
3xHindIII
BspEI
XhoI / NotI
M
C
S
p
A
HindIII EcoRI
Backbone
BspEI
XhoI / NotI
pR26-mT/mG (TV)
pmT/mG
pUC-loxP-EGFP-pA pUC-loxP-MCS-pA
PacI/AscI
(in pLinker3)
HindIII/EcoRI
(in pUC19)
BspEI/XhoI/NotI
Replace mG by MCS
 
Generation of a pR26-CAG-mT/cGi targeting vector (II)
5' HA CAG mT mG
p
A
p
A
PGK-Neo
p
A
3' HA Backbone
PacI AscI
CAG mT mG
p
A
p
A
PGK-Neo
p
A
PacI AscI
Backbone
NgoMIV HindIII EcoRI
HindIII EcoRI
mG
p
A
HindIII EcoRI
Backbone
EcoRI
HindIII
3xHindIII
BspEI
XhoI / NotI
M
C
S
p
A
HindIII EcoRI
Backbone
BspEI
XhoI / NotI
pR26-mT/mG (TV)
pmT/mG
pUC-loxP-EGFP-pA pUC-loxP-MCS-pA
PacI/AscI
back into pR26
MCS
HindIII/EcoRI
back into pmT/mG
HindIII/EcoRI
(in pUC19)
BspEI/XhoI/NotI
Replace mG by MCS
MCS
MCSMCS
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II. Plasmid 
Cards
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PLASMID NO.: BB1 
 
NAME OF PLASMID:  pROSA26 mT/mG 
 
CONSTRUCTED BY: Liqun Luo BOX NO.: 
MAXI IV 
(Tübingen) 
REFERENCE: 
Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L: 
A global double-fluorescent Cre reporter mouse. 
Genesis. 2007 Sep . 45(9):593-605. 
DATE: 10.02.2009 
ACCESSION NO: PMID 17868096, Addgene plasmid 17787 CONC. (µG/µL): 0.75 
 
TOTAL SIZE (BP): 17098 HOST: E. Coli XL1-Blue 
VECTOR SIZE (BP): 4969 BACKBONE: pBluescript 
INSERT SIZE (BP):  GENETIC MARKER: Amp 
 
DESCRIPTION/CONSTRUCTION DETAILS: 
See referenced publication or Addgene database (plasmid 17787). 
Generation and Testing of the mT/mG Targeting Construct: […] The mT/mG construct was assembled within a modified pBluescript II expression vector 
(pBluescript II0) with a SalI-SpeI-XhoI-SacII-NdeI multi-cloning site. The SpeI-XhoI restriction fragment of p302 (GenBank accession number U51223, a gift 
from Dr. B. Sauer) (Sauer, 1993) was subcloned into pBluescript II0. The XhoIBamHI restriction fragment of p302 was subcloned into the standard pBluescript 
vector, and the BamHI site was modified to a SacII site with oligonucleotides. The XhoISacII restriction fragment was introduced into pBluescript II0 to make 
SalI-loxP-pA-loxP-SacII-NdeI (p302-1). Restriction sites BamHI and XhoI were introduced into the 50 and 30 ends of mT by PCR and this PCR fragment was 
subcloned into pGEM-T (Promega), sequenced, and then introduced into p302-1 to make loxP-mT-pA-loxP. Restriction sites SacII and NdeI were introduced 
into the 50 and 30 ends of the mG-pA by PCR. This PCR fragment was subcloned into pGEM-T, sequenced, and then introduced into the loxP-mT-pA-loxP 
vector to make loxP-mTpA-loxP-mG-pA0. Finally, the 150-bp SacII fragment of the GFP N-terminus region was subcloned into loxP-mT-pAloxP-mG-pA0 to 
make loxP-mT-pA-loxP-mG-pA (mT/mG) flanked by the restriction sites SalI and NdeI. The mT/mG sequence excised with SalI and NdeI was subcloned into 
an expression vector containing a CMV chicken bactin enhancer-promoter (pCA-HZ2) (Zong et al., 2005) by blunt end ligation. Orientation of pCA-mT/mG was 
verified by BamHI restriction digest. […] Following verification of construct function in vitro, an FRT-flanked Neo cassette (selectable marker) was subcloned 
distal to the mG-pA in pCA-mT/mG via EcoRI and AscI restriction sites added to the 50 and 30 ends of pL451 (NCI) (Liu et al., 2003). The resulting vector was 
sequenced, cut with PacI and AscI, and subcloned into the ROSA26 targeting vector (Srinivas et al., 2001). 
 
MAP: 
 
 
DATE VERSION EDITOR      
10.2.2009 1 Martin Thunemann     
 
Rosa26 mT/mG
17098 bp
Orf frame 2 (1847-2455)
Orf frame 1 (2818-4437)
D sR ed2(36-672) (2938-4392)
EGFP (5353-6198)
N eom ycin (7146-7949)
Orf frame 3 (12927-13817)
Am picillin  (15450-16310)
C AG en h an cer  (1185-1472)
SV40 in t (4475-4490)
SV40 3 sp l ice (4496-4543)
SV40 in t (13818-13833)
SV40 3 sp l ice (13839-13886)
lacZ  a (16897-17052)
FRT-P G K-Ne o-FRT
lox P -Ds Re d-lox P
T3 promoter
lac prom oter
Am pR  prom oter
T7 promoter
P1 Promoter
p B R 322 o rig in
f1 o rig in
SV40 PA terminator
bGH PA terminator
bGH PA terminator
bGH PA terminator
3'-HA (8335-12551)
5'-HA (5-1083)
Kpn I (14237)
PacI (1093)
Pme I (1102)
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PLASMID NO.: MTH022 
 
NAME OF PLASMID: pLinker3 
 
CONSTRUCTED BY: Martin Thunemann BOX NO.: Maxi IV Tübingen 
REFERENCE:  DATE: 26.03.2009 
ACCESSION NO:  
CONC. 
(µG/µL): 
1 
 
TOTAL SIZE (BP): 2677 HOST: E. coli XL1-blue 
VECTOR SIZE (BP): 2635 BACKBONE: pUC19 
INSERT SIZE (BP): 42 GENETIC MARKER: Ampicillin 
 
DESCRIPTION/CONSTRUCTION DETAILS: 
Hybridized and phosphorylated plinker3_fwd and pLinker3_rev linker oligos building a cloning 
site with PacI, FseI, NotI, SmiI, AscI restriction sites were ligated into EcoRI/HindIII digested 
pUC19. 
 
MAP: 
pLinker3
2677 bp
AP r  (1620-2477)
ALPHA (149-462)
P(BLA)
P(LAC)
OR I
AscI (433)
FseI (413)
NotI (417)
PacI (404)
SmiI (427)
 
pLinker3_fwd: AAT TAA TTA AGG CCG GCC GCG GCC GCA TTT AAA TGG CGC GCC 
pLinker3_rev: AGC TGG CGC GCC ATT TAA ATG CGG CCG CGG CCG GCC TTA ATT 
 
DATE VERSION EDITOR      
6.4.2009 4 Martin Thunemann     
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PLASMID NO.: AV001 
 
NAME OF PLASMID: pmTmG 
 
CONSTRUCTED BY: Angelos Vachaviolos BOX NO.: Maxi IV Tübingen 
REFERENCE:  DATE: 24.04.2010 
ACCESSION NO:  
CONC. 
(µG/µL): 
1 
 
TOTAL SIZE (BP): 9884 HOST: E. coli XL1-blue 
VECTOR SIZE (BP): 2648 BACKBONE: pUC19 
INSERT SIZE (BP): 7236 GENETIC MARKER: Ampicillin 
 
DESCRIPTION/CONSTRUCTION DETAILS: 
The plasmid mTmG contains a loxP-flanked mT (tdTomato) downstream of the CAG promoter, 
followed by a mGFP and a FRT-PGK-Neo-FRT element.   
To generate the mTmG plasmid (9884 bp), pROSA26-mT/mG plasmid (L. Luo) was digested 
with PacI and AscI restriction enzymes producing a 7236 bp size fragment. This fragment was 
subcloned into the PacI, AscI digested pLinker3 plasmid (2648 bp, M. Thunemann).  
The construct shows expression of mT after transfecton in COS-7 cells and expression of mG 
after co-transfection with Cre in COS-7 cells. 
 
MAP: 
 
 
 
        
pmTmG
9884 bp
AP r
Neomycin
EGFP
DsRed2(36-672)
Orf frame 1
Orf frame 2
CAG enhancer
intron AG promotor
SV40 int
loxP-DsRed-loxP
FRT-PGK-Neo-FRT
AG promoter
P(LAC)
P(BLA)
P1 Promoter ORI
SV40 3 splice
bGH PA terminator
bGH PA terminator
SV40 PA terminator
putative mRNA
AscI (1)
EcoRI (8022)
Hin dIII (6821) Pac I (2649)
Xho I (5950)
Xho I (7764)
Kpn2I (4486)
Kpn2I (6892)
Kpn2I (8545)
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PLASMID NO.: AV002 
 
NAME OF PLASMID: pUC-loxP-EGFP-pA 
 
CONSTRUCTED BY: Angelos Vachaviolos BOX NO.: Maxi IV Tübingen 
REFERENCE:  DATE: 07.05.2010 
ACCESSION NO:  
CONC. 
(µG/µL): 
1 
 
TOTAL SIZE (BP): 3836 HOST: E. coli XL1-blue 
VECTOR SIZE (BP): 2635 BACKBONE: pUC19 
INSERT SIZE (BP): 1201 GENETIC MARKER: Ampicillin 
 
DESCRIPTION/CONSTRUCTION DETAILS: 
loxP-mG-pA fragment from pmT/mG digested with EcoRI/HindIII, was subcloned into 
EcoRI/HindIII digested pUC19. 
 
MAP: 
 
  
 
        
       
ploxP-mG-pA
3836 bp
EGFP
APr
P(LAC)
P(BLA)
ORI
bGH PA terminator
EcoRI (1)
HindIII (1202)
XhoI (259)
Kpn2I (1131)
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PLASMID NO.: AV003 
 
NAME OF PLASMID: pUC-loxP-MCS-pA 
 
CONSTRUCTED BY: Angelos Vachaviolos BOX NO.: Maxi IV Tübingen 
REFERENCE:  DATE: 01.06.2010 
ACCESSION NO:  
CONC. 
(µG/µL): 
1 
 
TOTAL SIZE (BP): 3004 HOST: E. coli XL1-blue 
VECTOR SIZE (BP): 2964 BACKBONE: pUC19 
INSERT SIZE (BP): 40 GENETIC MARKER: Ampicillin 
 
DESCRIPTION/CONSTRUCTION DETAILS: 
To generate the pUC-loxp-MCS-pA plasmid, the mG fragment was excised from pUC-loxP-
EGFP-pA by Kpn2I/XhoI and replaced with an oligo for FseI,MluI,XmaI,AsiSI restriction sites.  
 
MAP: 
 
 MCS_fwd: CCGGAGGCCGGCCGGGTATCAGTGGCGATCGCACGCGTC 
 MCS_rev: TCGAGACGCGTGCGATCGCCACTGATACCCGGGCCGGCCT 
 
        
       
ploxP-MCS-pA
3004 bp
AP r
P(BLA)
P(LAC)
ORI
bGH PA terminator
EcoRI (2707)
HindIII (72)
Kpn2I (1)
XhoI (2965)
Asi SI (2981)
Fse I (3002)
MluI (2971)
XmaI (2993)
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PLASMID NO.: AV004 
 
NAME OF PLASMID: pLinker5 
 
CONSTRUCTED BY: Angelos Vachaviolos BOX NO.: Maxi IV Tübingen 
REFERENCE:  DATE: 01.06.2010 
ACCESSION NO:  
CONC. 
(µG/µL): 
1 
 
TOTAL SIZE (BP): 2687 HOST: E. coli XL1-blue 
VECTOR SIZE (BP): 2635 BACKBONE: pUC19 
INSERT SIZE (BP): 52 GENETIC MARKER: Ampicillin 
 
DESCRIPTION/CONSTRUCTION DETAILS: 
Hybridized and phosphorylated AV_Linker_rev and AV_Linker_fwd oligos building a cloning site 
with FseI, NcoI, HindIII, BamHI, EcoRI, MluI restriction sites, were ligated into EcoRI/HindIII 
digested pUC19. 
 
MAP: 
 
AV_Linker_rev: AGC TGC GAT CGC ACG CGT GAA TTC GGA TCC AAG CTT CCA TGG CTG GCC GGC C 
AV_Linker_fwd: AAT TGG CCG GCC AGC CAT GGA AGC TTG GAT CCG AAT TCA CGC GTG CGA TCG C  
 
        
pLinker5
2687 bp
AP r
ALPHA
P(BLA)
P(LAC)
ORI
EcoRI (430)
Fse I (407)
HindIII (418)
Nco I (412)
BamHI (424)
Mlu I (436)
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PLASMID NO.: AV005 
 
NAME OF PLASMID: pmT/MCS 
 
CONSTRUCTED BY: Angelos Vachaviolos BOX NO.: Maxi IV Tübingen 
REFERENCE:  DATE: 15.06.2010 
ACCESSION NO:  
CONC. 
(µG/µL): 
1 
 
TOTAL SIZE (BP): 9052 HOST: E. coli XL1-blue 
VECTOR SIZE (BP): 2648 BACKBONE: pUC19 
INSERT SIZE (BP): 6404 GENETIC MARKER: Ampicillin 
 
DESCRIPTION/CONSTRUCTION DETAILS: 
The plasmid mT/MCS contains a loxP-flanked mT (tdTomato) downstream of the CAG promoter, 
followed by a Multiple Cloning site for FseI, AsiSI, MluI, XmaI  and a FRT-PGK-Neo-FRT 
element.   
To generate the mT/MCS plasmid (9052 bp), pmT/mG plasmid was modified and the mG 
fragment was removed with EcoRI and HindIII and replaced by a MCS.  
 
 
MAP: 
 
 
 
        
       
pmT/MCS
9052 bp
AP r Orf frame 2
Orf frame 1
DsRed2(36-672)
Neomycin
CAG enhancer
SV40 int
intron AG promotor
loxP-DsRed-loxP
FRT-PGK-Neo-FRT
AG promoter
P(BLA)
P(LAC)
P1 Promoter
ORI
SV40 3 splice
bGH PA terminator
SV40 PA terminator
bGH PA terminator
putativ e  mRNA
Asi SI (4274)
Fse I (4255)EcoRI (4542)
Asc I (6405)
PacI (1)
Mlu I (4278)
XmaI (4256)
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PLASMID NO.: AV006 
 
NAME OF PLASMID: pmT/cGi500 
 
CONSTRUCTED BY: Angelos Vachaviolos BOX NO.: Maxi IV Tübingen 
REFERENCE:  DATE: 26   .06.2010 
ACCESSION NO:  
CONC. 
(µG/µL): 
1 
 
TOTAL SIZE (BP): 11297 HOST: E. coli XL1-blue 
VECTOR SIZE (BP): 9033 BACKBONE: pUC19 
INSERT SIZE (BP): 2264 GENETIC MARKER: Ampicillin 
 
DESCRIPTION/CONSTRUCTION DETAILS: 
The plasmid mT/cGi500 contains a loxP-flanked mT (tdTomato) downstream of the CAG 
promoter, followed by a Fret-based cGMP sensor (cGi500) and a FRT-PGK-Neo-FRT element.   
To generate the mT/cGi500 plasmid (11297 bp), mT/MCS plasmid was digested with FseI and 
AsiSI producing a 9033bp vector to host the FseI, AsiSI digested pl5cGi500 fragment (2264bp). 
 
 
MAP: 
 
 
 
        
       
pmT/cGi500
11297 bp
Neomycin
DsRed2(36-672)
Orf frame 1
Orf frame 2
AP r
cGMP-BD A+B (Gln79-Tyr345)
YFP
CFP
CAG enhancer
intron AG promotor
SV40 int
FRT-PGK-Neo-FRT
loxP-DsRed-loxP
AG promoter
P1 Promoter
P(LAC)
P(BLA)
ORI
SV40 3 splice
bGH PA terminator
SV40 PA terminator
bGH PA terminator
putativ e mRNA
Asc I (2132)
PacI (4780)
Asi SI (1)
Fse I (9034)
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 04:38:13 EET - 137.108.70.7
93 
 
 
PLASMID NO.: AV007 
 
NAME OF PLASMID: pmT/sr39tk                              
 
CONSTRUCTED BY: Angelos Vachaviolos BOX NO.: Maxi IV Tübingen 
REFERENCE:  DATE: 08 .07.2010 
ACCESSION NO:  
CONC. 
(µG/µL): 
1 
 
TOTAL SIZE (BP): 10214 HOST: E. coli XL1-blue 
VECTOR SIZE (BP): 9033 BACKBONE: pUC19 
INSERT SIZE (BP): 1181 GENETIC MARKER: Ampicillin 
 
DESCRIPTION/CONSTRUCTION DETAILS: 
The plasmid mT/sr39tk contains a loxP-flanked mT (tdTomato) downstream of the CAG 
promoter, followed by a sr39 thymidine kinase and a FRT-PGK-Neo-FRT element.   
To generate the mT/sr39tk plasmid (10214 bp), mT/MCS plasmid was digested with FseI and 
AsiSI producing a 9033bp vector to host the FseI, AsiSI digested pl5sr39tk fragment(1181bp). 
 
 
MAP: 
 
 
 
        
       
 
pmT/sr39tk
10214 bp
Neomycin
DsRed2(36-672)
Orf frame 1
Orf frame 2
AP r
CAG enhancer
intron AG promotor
SV40 int
FRT-PGK-Neo-FRT
loxP-DsRed-loxP
AG promoter
P1 Promoter
P(LAC)
P(BLA)
ORI
SV40 3 splice
bGH PA terminator
SV40 PA terminator
bGH PA terminatorputativ e mRNA
[2007-05-13] ACCACG replaced by ACG †
[2007-05-13] GC replaced by GGGCATGC †
[2007-05-13] A replaced by C †
Asc I (3313)
PacI (5961)
Fse I (1)
Asi SI (1182)
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PLASMID NO.: AV008 
 
NAME OF PLASMID: Rosa26 mT/cGi500 (Targeting Vector) 
 
CONSTRUCTED BY: Angelos Vachaviolos BOX NO.: Maxi IV Tübingen 
REFERENCE:  DATE: - 
ACCESSION NO:  
CONC. 
(µG/µL): 
1 
 
TOTAL SIZE (BP): 18497 HOST: E. coli XL1-blue 
VECTOR SIZE (BP): 9862 BACKBONE: pUC19 
INSERT SIZE (BP): 8635 GENETIC MARKER: Ampicillin 
 
DESCRIPTION/CONSTRUCTION DETAILS: 
The plasmid Rosa26 mT/cGi500 contains a loxP-flanked mT (tdTomato) downstream of the 
CAG promoter, followed by a Fret-based cGMP sensor (cGi500) and a FRT-PGK-Neo-FRT 
element.   
To generate the Rosa26 mT/cGi500 plasmid (18497 bp), Rosa26 mT/mG plasmid was digested 
with AscI/PacI producing a 9862bp vector to host the AscI/PacI digested pmTcGi500 fragment 
(8635bp). 
 
 
MAP: 
 
 
 
        
       
 
Rosa26 mT/cGi500
184 9 7 bp
cGMP-B D  A+B  (Gln 79-Tyr345)
YF P
C F P
Orf frame 3
Amp icil l in
Orf frame 2
Orf frame 1
D sR ed 2(36-672)
N eomycin
C AG en h an cer
SV40 in t
in tro n  AG p ro mo tor
SV40 in t
SV40 3 sp lice
lacZ  a
lo xP-D sR ed -loxP
F R T-PGK -N eo -F R T
AG p ro moter
T3 p ro mo ter
lac p ro mo ter
Amp R  promo ter
T7 p ro mo ter
P1 Pro mo ter
p B R 322 o rig in
f1 o r ig in
SV40 3 sp lice
b GH  PA termin ato r
b GH  PA termin ato rSV40 PA terminator
b GH  PA termin ato r
p u tative mR N A
3'-H A
5'-H A
Asc I (2128)
FseI (16 24 4 )
PacI (119 9 0)
MluI (1)
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PLASMID NO.: AV009 
 
NAME OF PLASMID: Rosa26 mT/sr39tk (Targeting Vector)                              
 
CONSTRUCTED BY: Angelos Vachaviolos BOX NO.: Maxi IV Tübingen 
REFERENCE:  DATE: - 
ACCESSION NO:  
CONC. 
(µG/µL): 
1 
 
TOTAL SIZE (BP): 17428 HOST: E. coli XL1-blue 
VECTOR SIZE (BP): 9862 BACKBONE: pUC19 
INSERT SIZE (BP): 7566 GENETIC MARKER: Ampicillin 
 
DESCRIPTION/CONSTRUCTION DETAILS: 
The plasmid Rosa26 mT/sr39tk contains a loxP-flanked mT (tdTomato) downstream of the CAG 
promoter, followed by a sr39 thymidine kinase and a FRT-PGK-Neo-FRT element.   
To generate the Rosa26 mT/sr39tk plasmid (17428 bp), Rosa26 mT/mG plasmid was digested 
with AscI/PacI producing a 9862bp vector to host the AscI/PAcI digested pmT/sr39tk 
fragment(7566bp). 
 
 
MAP: 
 
 
 
        
Rosa26 mT/sr39tk
174 28 bp
Orf frame 3
Ampicillin
Orf frame 2
Orf frame 1
DsRed2(36-672)
Neomycin
CAG enhancer
SV40 int
intron AG promotor
SV40 int
SV40 3 splice
lacZ a
loxP-DsRed-loxP
FRT-PGK-Neo-FRT
AG promoter
T3 promoter
lac promoter
AmpR promoter
T7 promoter
P1 Promoter
pBR322 origin
f1 origin
SV40 3 splice
bGH PA terminator
bGH PA terminator
SV40 PA terminator
bGH PA terminatorputative mRNA
[2007-05-13] ACCACG replaced by ACG †
[2007-05-13] GC replaced by GGGCATGC †
[2007-05-13] A replaced by C †
3'-HA
5'-HA
Asc I (2132)
PacI (119 94 )
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PLASMID NO.: AV010 
 
NAME OF PLASMID: Rosa26 mT/MCS (Targeting Vector) 
 
CONSTRUCTED BY: Angelos Vachaviolos BOX NO.: Maxi IV Tübingen 
REFERENCE:  DATE: - 
ACCESSION NO:  
CONC. 
(µG/µL): 
1 
 
TOTAL SIZE (BP): 16266 HOST: E. coli XL1-blue 
VECTOR SIZE (BP): 9862 BACKBONE: pUC19 
INSERT SIZE (BP): 6472 GENETIC MARKER: Ampicillin 
 
DESCRIPTION/CONSTRUCTION DETAILS: 
The plasmid Rosa26 mT/MCS contains a loxP-flanked mT (tdTomato) downstream of the CAG 
promoter, followed by a Multiple Cloning Site and a FRT-PGK-Neo-FRT element.   
To generate the Rosa26 mT/MCS plasmid (16266 bp), Rosa26 mT/mG plasmid was digested with 
AscI/PacI producing a 9862bp vector to host the AscI/PacI digested pmTMCS fragment (6742bp). 
 
 
MAP: 
 
 
 
        
Rosa26 mT/MCS
16266 bp
Neomycin
DsRed2(36-672)
Orf frame 1
Orf frame 2
Ampicillin
Orf frame 3
CAG enhancer
intron AG promotor
SV40 int
lacZ a
SV40 3 splice
SV40 int
FRT-PGK-Neo-FRT
loxP-DsRed-loxP
AG promoter
P1 Promoter
T7 promoter
AmpR promoter
lac promoter
T3 promoter
f1 origin
pBR322 origin
SV40 3 splice
bGH PA terminator
SV40 PA terminator
bGH PA terminator
bGH PA terminator
putative mRNA
5'-HA
3'-HA
Asc I (6405)
PacI (1)
Asi SI (4274)
Fse I (4255)
Mlu I (4278)
XmaI (4256)
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ΙΙΙ. Cell Culture Plan 
 
 
 
Per well has been used: 
2μg of pUC19 
2μg of pIC-Cre 
3μg of pmTmG 
3μg of pmTcGi500 
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IV. Abbreviations 
Amp: Ampicillin 
bp: base pairs 
CFP: Cyan Fluorescent Protein 
cGMP: cyclic Guanosine Monophosphate 
dH2O: de-ionized water  
EDTA: Ethylene Diamine Tetra Acetate  
FRET: Fluorescence Resonance Energy transfer 
GC: Guanylyl Cyclase 
GFP: Green Fluorescent Protein 
Kb: kilo bases 
MCS: Multiple Cloning Site 
MEF: Mouse Embryonic Fibroblast 
mG: membrane targeted GFP 
mT: membrane targeted td Tomato 
Neo: neomycin 
OD: Optical Density 
SSR: Site Specific Recombinase 
tk: thymidine kinase 
YFP: Yellow Fluorescent Protein 
         : loxP site 
         : FRT site    
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